Human Genetics

, Volume 125, Issue 5–6, pp 467–491 | Cite as

Molecular genetics of atherosclerosis

  • Himadri Roy
  • Shalini Bhardwaj
  • Seppo Yla-Herttuala
Review Article

Abstract

Atherosclerosis is a complex multifocal arterial disease involving interactions of multiple genetic and environmental factors. Advances in techniques of molecular genetics have revealed that genetic polymorphisms significantly influence susceptibility to atherosclerotic vascular diseases. A large number of candidate genes, genetic polymorphisms and susceptibility loci associated with atherosclerotic diseases have been identified in recent years and their number is rapidly increasing. In this review we focus on some of the major candidate genes and genetic polymorphisms associated with human atherosclerotic vascular diseases.

References

  1. Abboud S, Karhunen PJ, Lütjohann D, Goebeler S, Luoto T, Friedrichs S, Lehtimaki T, Pandolfo M, Laaksonen R (2007) Proprotein convertase subtilisin/kexin type 9 (PCSK9) gene is a risk factor of large-vessel atherosclerosis stroke. PLoS ONE 2:e1043PubMedCrossRefGoogle Scholar
  2. Abifadel M, Varret M, Rabès JP, Allard D, Ouguerram K, Devillers M, Cruaud C, Benjannet S, Wickham L, Erlich D, Derré A, Villéger L, Farnier M, Beucler I, Bruckert E, Chambaz J, Chanu B, Lecerf JM, Luc G, Moulin P, Weissenbach J, Prat A, Krempf M, Junien C, Seidah NG, Boileau C (2003) Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat Genet 34:154–156PubMedCrossRefGoogle Scholar
  3. Abilleira S, Bevan S, Markus HS (2006) The role of genetic variants of matrix metalloproteinases in coronary and carotid atherosclerosis. J Med Genet 43:897–901PubMedCrossRefGoogle Scholar
  4. Agema WR, de Maat MP, Zwinderman AH, Kastelein JJ, Rabelink TJ, van Boven AJ, Feskens EJ, Boer JM, van der Wall EE, Jukema JW (2004) An integrated evaluation of endothelial constitutive nitric oxide synthase polymorphisms and coronary artery disease in men. Clin Sci (Lond) 107:255–261Google Scholar
  5. Allen RA, Lee EM, Roberts DH, Park BK, Pirmohamed M (2001) Polymorphisms in the TNF-alpha and TNF-receptor genes in patients with coronary artery disease. Eur J Clin Invest 31:843–851PubMedCrossRefGoogle Scholar
  6. Allen A, Belton C, Patterson C, Horan P, McGlinchey P, Spence M, Evans A, Fogarty D, McKeown P (2005) Family-based association studies of lipid gene polymorphisms in coronary artery disease. Am J Cardiol 96:52–55PubMedCrossRefGoogle Scholar
  7. Al-Shali KZ, House AA, Hanley AJ, Khan HM, Harris SB, Zinman B, Mamakeesick M, Fenster A, Spence JD, Hegele RA (2004) Genetic variation in PPARG encoding peroxisome proliferator-activated receptor gamma associated with carotid atherosclerosis. Stroke 35:2036–2040PubMedCrossRefGoogle Scholar
  8. Ameziane N, Beillat T, Verpillat P, Chollet-Martin S, Aumont MC, Seknadji P, Lamotte M, Lebret D, Ollivier V, de Prost D (2003) Association of the Toll-like receptor 4 gene Asp299Gly polymorphism with acute coronary events. Arterioscler Thromb Vasc Biol 23:e61–e64PubMedCrossRefGoogle Scholar
  9. Andersen RV, Wittrup HH, Tybjaerg-Hansen A, Steffensen R, Schnohr P, Nordestgaard BG (2003) Hepatic lipase mutations, elevated high-density lipoprotein cholesterol, and increased risk of ischemic heart disease: the Copenhagen City Heart Study. J Am Coll Cardiol 41:1972–1982PubMedCrossRefGoogle Scholar
  10. Arnett DK, Baird AE, Barkley RA, Basson CT, Boerwinkle E, Ganesh SK, Herrington DM, Hong Y, Jaquish C, McDermott DA, O’Donnell CJ, American Heart Association Council on Epidemiology and Prevention; American Heart Association Stroke Council; Functional Genomics and Translational Biology Interdisciplinary Working Group (2007) Relevance of genetics and genomics for prevention and treatment of cardiovascular disease: a scientific statement from the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation 115:2878–2901PubMedCrossRefGoogle Scholar
  11. Assimes TL, Knowles JW, Priest JR, Basu A, Volcik KA, Southwick A, Tabor HK, Hartiala J, Allayee H, Grove ML, Tabibiazar R, Sidney S, Fortmann SP, Go A, Hlatky M, Iribarren C, Boerwinkle E, Myers R, Risch N, Quertermous T (2008) Common polymorphisms of ALOX5 and ALOX5AP and risk of coronary artery disease. Hum Genet 123:399–408PubMedCrossRefGoogle Scholar
  12. Atherosclerosis Thrombosis, Group Vascular Biology Italian Study (2003) No evidence of association between prothrombotic gene polymorphisms and the development of acute myocardial infarction at a young age. Circulation 107:1117–1122CrossRefGoogle Scholar
  13. Balistreri CR, Candore G, Colonna-Romano G, Lio D, Caruso M, Hoffmann E, Franceschi C, Caruso C (2004) Role of Toll-like receptor 4 in acute myocardial infarction and longevity. JAMA 292:2339–2340PubMedCrossRefGoogle Scholar
  14. Barter PJ, Rye KA (2006) The rationale for using apoA-I as a clinical marker of cardiovascular risk. J Intern Med 259:447–454PubMedCrossRefGoogle Scholar
  15. Benjafield AV, Wang XL, Morris BJ (2001) Tumor necrosis factor receptor 2 gene (TNFRSF1B) in genetic basis of coronary artery disease. J Mol Med 79:109–115PubMedCrossRefGoogle Scholar
  16. Bennet AM, Prince JA, Fei GZ, Lyrenäs L, Huang Y, Wiman B, Frostegård J, Faire U (2003) Interleukin-6 serum levels and genotypes influence the risk for myocardial infarction. Atherosclerosis 171:359–367PubMedCrossRefGoogle Scholar
  17. Berge KE, Tian H, Graf GA, Yu L, Grishin NV, Schultz J, Kwiterovich P, Shan B, Barnes R, Hobbs HH (2000) Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science 290:1771–1775PubMedCrossRefGoogle Scholar
  18. Berglund L, Ramakrishnan R (2004) Lipoprotein(a): an elusive cardiovascular risk factor. Arterioscler Thromb Vasc Biol 24:2219–2226PubMedCrossRefGoogle Scholar
  19. Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, Watson AD, Lusis AJ (1995) Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation 91:2488–2496PubMedGoogle Scholar
  20. Bevan S, Porteous L, Sitzer M, Markus HS (2005) Phosphodiesterase 4D gene, ischemic stroke, and asymptomatic carotid atherosclerosis. Stroke 36:949–953PubMedCrossRefGoogle Scholar
  21. Bhagavatula MR, Fan C, Shen GQ, Cassano J, Plow EF, Topol EJ, Wang Q (2004) Transcription factor MEF2A mutations in patients with coronary artery disease. Hum Mol Genet 13:3181–3188PubMedCrossRefGoogle Scholar
  22. Bi N, Yan SK, Li GP, Yin ZN, Chen BS (2004) A single nucleotide polymorphism −1131T>C in the apolipoprotein A5 gene is associated with an increased risk of coronary artery disease and alters triglyceride metabolism in Chinese. Mol Genet Metab 83:280–286PubMedCrossRefGoogle Scholar
  23. Blanc J, Alves-Guerra MC, Esposito B, Rousset S, Gourdy P, Ricquier D, Tedgui A, Miroux B, Mallat Z (2003) Protective role of uncoupling protein 2 in atherosclerosis. Circulation 107:388–390PubMedCrossRefGoogle Scholar
  24. Blanco E, Moñux G, Mas A, Serrano FJ, de la Concha EG, Urcelay E (2008) Role of IL-10 promoter polymorphisms in the development of severe aorto-iliac occlusive disease. Hum Immunol 69(10):651–654PubMedCrossRefGoogle Scholar
  25. Bobik A (2006) Transforming growth factor-betas and vascular disorders. Arterioscler Thromb Vasc Biol 26:1712–1720PubMedCrossRefGoogle Scholar
  26. Bodzioch M, Orso E, Klucken J, Langmann T, Bottcher A, Diederich W, Drobnik W, Barlage S, Buchler C, Porsch-Ozcurumez M, Kaminski WE, Hahmann HW, Oette K, Rothe G, Aslanidis C, Lackner KJ, Schmitz G (1999) The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Genet 22:347–351PubMedCrossRefGoogle Scholar
  27. Boekholdt SM, Bijsterveld NR, Moons AH, Levi M, Büller HR, Peters RJ (2001) Genetic variation in coagulation and fibrinolytic proteins and their relation with acute myocardial infarction: a systematic review. Circulation 104:3063–3068PubMedCrossRefGoogle Scholar
  28. Boekholdt SM, Trip MD, Peters RJ, Engelen M, Boer JM, Feskens EJ, Zwinderman AH, Kastelein JJ, Reitsma PH (2002) Thrombospondin-2 polymorphism is associated with a reduced risk of premature myocardial infarction. Arterioscler Thromb Vasc Biol 22:e24–e27PubMedCrossRefGoogle Scholar
  29. Boekholdt SM, Kuivenhoven JA, Hovingh GK, Jukema JW, Kastelein JJ, van Tol A (2004a) CETP gene variation: relation to lipid parameters and cardiovascular risk. Curr Opin Lipidol 15:393–398PubMedCrossRefGoogle Scholar
  30. Boekholdt SM, Kuivenhoven JA, Wareham NJ, Peters RJ, Jukema JW, Luben R, Bingham SA, Day NE, Kastelein JJ, Khaw KT (2004b) Plasma levels of cholesteryl ester transfer protein and the risk of future coronary artery disease in apparently healthy men and women: the prospective EPIC (European Prospective Investigation into Cancer and nutrition)-Norfolk population study. Circulation 110:1418–1423PubMedCrossRefGoogle Scholar
  31. Boekholdt SM, Sacks FM, Jukema JW, Shepherd J, Freeman DJ, McMahon AD, Cambien F, Nicaud V, de Grooth GJ, Talmud PJ, Humphries SE, Miller GJ, Eiriksdottir G, Gudnason V, Kauma H, Kakko S, Savolainen MJ, Arca M, Montali A, Liu S, Lanz HJ, Zwinderman AH, Kuivenhoven JA, Kastelein JJ (2005) Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects. Circulation 111:278–287PubMedCrossRefGoogle Scholar
  32. Boerma M, Forsberg L, Van Zeijl L, Morgenstern R, De Faire U, Lemne C, Erlinge D, Thulin T, Hong Y, Cotgreave IA (1999) A genetic polymorphism in connexin 37 as a prognostic marker for atherosclerotic plaque development. J Intern Med 246:211–218PubMedCrossRefGoogle Scholar
  33. Borggreve SE, Hillege HL, Wolffenbuttel BH, de Jong PE, Zuurman MW, van der Steege G, van Tol A, Dullaart RP, PREVEND Study Group (2006) An increased coronary risk is paradoxically associated with common cholesteryl ester transfer protein gene variations that relate to higher high-density lipoprotein cholesterol: a population-based study. J Clin Endocrinol Metab 91:3382–3388PubMedCrossRefGoogle Scholar
  34. Boucher P, Gotthardt M (2004) LRP and PDGF signaling: a pathway to atherosclerosis. Trends Cardiovasc Med 14:55–60PubMedCrossRefGoogle Scholar
  35. Brattström L, Wilcken DE, Ohrvik J, Brudin L (1998) Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis. Circulation 98:2520–2526PubMedGoogle Scholar
  36. Brewer HB Jr (1989) Clinical significance of plasma lipid levels. Am J Cardiol 64:3G–9GPubMedCrossRefGoogle Scholar
  37. Broadbent HM, Peden JF, Lorkowski S, Goel A, Ongen H, Green F, Clarke R, Collins R, Franzosi MG, Tognoni G, Seedorf U, Rust S, Eriksson P, Hamsten A, Farrall M, Watkins H, PROCARDIS consortium (2008) Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p. Hum Mol Genet 17:806–814PubMedCrossRefGoogle Scholar
  38. Brooks-Wilson A, Marcil M, Clee SM, Zhang LH, Roomp K, van Dam M, Yu L, Brewer C, Collins JA, Molhuizen HO, Loubser O, Ouelette BF, Fichter K, Ashbourne-Excoffon KJ, Sensen CW, Scherer S, Mott S, Denis M, Martindale D, Frohlich J, Morgan K, Koop B, Pimstone S, Kastelein JJ, Hayden MR (1999) Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet 22:336–345PubMedCrossRefGoogle Scholar
  39. Brousseau ME, Bodzioch M, Schaefer EJ, Goldkamp AL, Kielar D, Probst M, Ordovas JM, Aslanidis C, Lackner KJ, Bloomfield Rubins H, Collins D, Robins SJ, Wilson PW, Schmitz G (2001) Common variants in the gene encoding ATP-binding cassette transporter 1 in men with low HDL cholesterol levels and coronary heart disease. Atherosclerosis 154:607–611PubMedCrossRefGoogle Scholar
  40. Brousseau ME, O’Connor JJ Jr, Ordovas JM, Collins D, Otvos JD, Massov T, McNamara JR, Rubins HB, Robins SJ, Schaefer EJ (2002) Cholesteryl ester transfer protein TaqI B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency: Veterans Affairs HDL Cholesterol Intervention Trial. Arterioscler Thromb Vasc Biol 22:1148–1154PubMedCrossRefGoogle Scholar
  41. Cai H, Duarte N, Wilcken DE, Wang XL (1999) NADH/NADPH oxidase p22 phox C242T polymorphism and coronary artery disease in the Australian population. Eur J Clin Invest 29:744–748PubMedCrossRefGoogle Scholar
  42. Cambien F, Ricard S, Troesch A, Mallet C, Générénaz L, Evans A, Arveiler D, Luc G, Ruidavets JB, Poirier O (1996) Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-Temoin de l’Infarctus du Myocarde (ECTIM) Study. Hypertension 28:881–887PubMedGoogle Scholar
  43. Casas JP, Bautista LE, Humphries SE, Hingorani AD (2004) Endothelial nitric oxide synthase genotype and ischemic heart disease: meta-analysis of 26 studies involving 23028 subjects. Circulation 109:1359–1365PubMedCrossRefGoogle Scholar
  44. Cha SH, Lee JK, Lee JY, Kim HT, Ryu HJ, Han BG, Kim JW, Oh B, Kimm K, Shin HD, Park BL, Park S, Park HY, Jang Y (2007) Association of CCR2 polymorphisms with the number of closed coronary artery vessels in coronary artery disease. Clin Chim Acta 382:129–133PubMedCrossRefGoogle Scholar
  45. Chanson M, Kwak BR (2007) Connexin37: a potential modifier gene of inflammatory disease. J Mol Med 85:787–795PubMedCrossRefGoogle Scholar
  46. Chapman CM, Beilby JP, Humphries SE, Palmer LJ, Thompson PL, Hung J (2003) Association of an allelic variant of interleukin-6 with subclinical carotid atherosclerosis in an Australian community population. Eur Heart J 24:1494–1499PubMedCrossRefGoogle Scholar
  47. Chen YH, Lin SJ, Lin MW, Tsai HL, Kuo SS, Chen JW, Charng MJ, Wu TC, Chen LC, Ding YA, Pan WH, Jou YS, Chau LY (2002) Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients. Hum Genet 111:1–8PubMedCrossRefGoogle Scholar
  48. Chen SN, Ballantyne CM, Gotto AM Jr, Tan Y, Willerson JT, Marian AJ (2005) A common PCSK9 haplotype, encompassing the E670G coding single nucleotide polymorphism, is a novel genetic marker for plasma low-density lipoprotein cholesterol levels and severity of coronary atherosclerosis. J Am Coll Cardiol 45:1611–1619PubMedCrossRefGoogle Scholar
  49. Chen Y, Rollins J, Paigen B, Wang X (2007) Genetic and genomic insights into the molecular basis of atherosclerosis. Cell Metab 6:164–179PubMedCrossRefGoogle Scholar
  50. Chhabra S, Narang R, Lakshmy R, Das N (2005) APOA1-75 G to A substitution associated with severe forms of CAD, lower levels of HDL and apoA-I among Northern Indians. Dis Markers 21:169–174PubMedGoogle Scholar
  51. Chiodini BD, Barlera S, Franzosi MG, Beceiro VL, Introna M, Tognoni G (2003) APO B gene polymorphisms and coronary artery disease: a meta-analysis. Atherosclerosis 167:355–366PubMedCrossRefGoogle Scholar
  52. Cho HJ, Chae IH, Park KW, Ju JR, Oh S, Lee MM, Park YB (2002) Functional polymorphism in the promoter region of the gelatinase B gene in relation to coronary artery disease and restenosis after percutaneous coronary intervention. J Hum Genet 47:88–91PubMedCrossRefGoogle Scholar
  53. Cipollone F, Toniato E, Martinotti S, Fazia M, Iezzi A, Cuccurullo C, Pini B, Ursi S, Vitullo G, Averna M, Arca M, Montali A, Campagna F, Ucchino S, Spigonardo F, Taddei S, Virdis A, Ciabattoni G, Notarbartolo A, Cuccurullo F, Mezzetti A (2004) A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke. Identification of New Elements of Plaque Stability (INES) Study Group. JAMA 291:2221–2228PubMedCrossRefGoogle Scholar
  54. Clee SM, Zwinderman AH, Engert JC, Zwarts KY, Molhuizen HO, Roomp K, Jukema JW, van Wijland M, van Dam M, Hudson TJ, Brooks-Wilson A, Genest J Jr, Kastelein JJ, Hayden MR (2001) Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease. Circulation 103:1198–1205PubMedGoogle Scholar
  55. Cohen JC, Boerwinkle E, Mosley TH Jr, Hobbs HH (2006) Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med 354:1264–1272PubMedCrossRefGoogle Scholar
  56. Collings A, Islam MS, Juonala M, Rontu R, Kähönen M, Hutri-Kähönen N, Laitinen T, Marniemi J, Viikari JS, Raitakari OT, Lehtimäki TJ (2007) Associations between connexin37 gene polymorphism and markers of subclinical atherosclerosis: the Cardiovascular Risk in Young Finns Study. Atherosclerosis 195:379–384PubMedCrossRefGoogle Scholar
  57. Connelly JJ, Wang T, Cox JE, Haynes C, Wang L, Shah SH, Crosslin DR, Hale AB, Nelson S, Crossman DC, Granger CB, Haines JL, Jones CJ, Vance JM, Goldschmidt-Clermont PJ, Kraus WE, Hauser ER, Gregory SG (2006) GATA2 is associated with familial early-onset coronary artery disease. PLoS Genet 2:e139PubMedCrossRefGoogle Scholar
  58. Crivello A, Giacalone A, Scola L, Forte GI, Nuzzo D, Giacconi R, Cipriano C, Candore G, Mocchegiani E, Colonna-Romano G, Lio D, Caruso C (2006) Frequency of polymorphisms of signal peptide of TGF-beta1 and −1082G/A SNP at the promoter region of Il-10 gene in patients with carotid stenosis. Ann N Y Acad Sci 1067:288–293PubMedCrossRefGoogle Scholar
  59. Cui J, Randell E, Renouf J, Sun G, Green R, Han FY, Xie YG (2006) Thrombospondin-4 1186G>C (A387P) is a sex-dependent risk factor for myocardial infarction: a large replication study with increased sample size from the same population. Am Heart J 152:543.e1–543.e5CrossRefGoogle Scholar
  60. Cullen P, Funke H, Schulte H, Assmann G (1998) Lipoproteins and cardiovascular risk-from genetics to CHD prevention. Eur Heart J 19:C5–C11PubMedCrossRefGoogle Scholar
  61. Dallongeville J, Cottel D, Montaye M, Codron V, Amouyel P, Helbecque N (2006) Impact of APOA5/A4/C3 genetic polymorphisms on lipid variables and cardiovascular disease risk in French men. Int J Cardiol 106:152–156PubMedCrossRefGoogle Scholar
  62. de Grooth GJ, Klerkx AH, Stroes ES, Stalenhoef AF, Kastelein JJ, Kuivenhoven JA (2004) A review of CETP and its relation to atherosclerosis. J Lipid Res 45:1967–1974PubMedCrossRefGoogle Scholar
  63. Dhamrait SS, Stephens JW, Cooper JA, Acharya J, Mani AR, Moore K, Miller GJ, Humphries SE, Hurel SJ, Montgomery HE (2004) Cardiovascular risk in healthy men and markers of oxidative stress in diabetic men are associated with common variation in the gene for uncoupling protein 2. Eur Heart J 25:468–475PubMedCrossRefGoogle Scholar
  64. Di Castelnuovo A, Soccio M, Iacoviello L, Evangelista V, Consoli A, Vanuzzo D, Diviacco S, Carluccio M, Rignanese L, De Caterina R (2008) The C242T polymorphism of the p22phox component of NAD(P)H oxidase and vascular risk. Two case-control studies and a meta-analysis. Thromb Haemost 99:594–601PubMedGoogle Scholar
  65. Dixon RA, Diehl RE, Opas E, Rands E, Vickers PJ, Evans JF, Gillard JW, Miller DK (1990) Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis. Nature 343:282–284PubMedCrossRefGoogle Scholar
  66. Djurić T, Zivković M, Radak D, Jekić D, Radak S, Stojković L, Raičević R, Stanković A, Alavantić D (2008) Association of MMP-3 5A/6A gene polymorphism with susceptibility to carotid atherosclerosis. Clin Biochem 41:1326–1329PubMedCrossRefGoogle Scholar
  67. Doevendans PA, Jukema W, Spiering W, Defesche JC, Kastelein JJ (2001) Molecular genetics and gene expression in atherosclerosis. Int J Cardiol 80:161–172PubMedCrossRefGoogle Scholar
  68. Doney AS, Fischer B, Leese G, Morris AD, Palmer CN (2004) Cardiovascular risk in type 2 diabetes is associated with variation at the PPARG locus: a Go-DARTS study. Arterioscler Thromb Vasc Biol 24:2403–2407PubMedCrossRefGoogle Scholar
  69. Dugi KA, Brandauer K, Schmidt N, Nau B, Schneider JG, Mentz S, Keiper T, Schaefer JR, Meissner C, Kather H, Bahner ML, Fiehn W, Kreuzer J (2001) Low hepatic lipase activity is a novel risk factor for coronary artery disease. Circulation 104:3057–3062PubMedCrossRefGoogle Scholar
  70. Dwyer JH, Allayee H, Dwyer KM, Fan J, Wu H, Mar R, Lusis AJ, Mehrabian M (2004) Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis. N Engl J Med 350:29–37PubMedCrossRefGoogle Scholar
  71. Edfeldt K, Swedenborg J, Hansson GK, Yan ZQ (2002) Expression of Toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation 105:1158–1161PubMedGoogle Scholar
  72. Efferth T (2003) Adenosine triphosphate-binding cassette transporter genes in ageing and age-related diseases. Ageing Res Rev 2:11–24PubMedCrossRefGoogle Scholar
  73. Eichner JE, Dunn ST, Perveen G, Thompson DM, Stewart KE, Stroehla BC (2002) Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am J Epidemiol 155:487–495PubMedCrossRefGoogle Scholar
  74. Eklund C, Kivimäki M, Islam MS, Juonala M, Kähönen M, Marniemi J, Lehtimäki T, Viikari J, Raitakari OT, Hurme M (2008) C-reactive protein genetics is associated with carotid artery compliance in men in The Cardiovascular Risk in Young Finns Study. Atherosclerosis 196:841–848PubMedCrossRefGoogle Scholar
  75. Eller P, Schgoer W, Mueller T, Tancevski I, Wehinger A, Ulmer H, Foeger B, Haltmayer M, Ritsch A, Patsch JR (2005) Hepatic lipase polymorphism and increased risk of peripheral arterial disease. J Intern Med 258:344–348PubMedCrossRefGoogle Scholar
  76. Elrayess MA, Webb KE, Flavell DM, Syvänne M, Taskinen MR, Frick MH, Nieminen MS, Kesäniemi YA, Pasternack A, Jukema JW, Kastelein JJ, Zwinderman AH, Humphries SE (2003) A novel functional polymorphism in the PECAM-1 gene (53G>A) is associated with progression of atherosclerosis in the LOCAT and REGRESS studies. Atherosclerosis 168:131–138PubMedCrossRefGoogle Scholar
  77. Espinola-Klein C, Rupprecht HJ, Bickel C, Schnabel R, Genth-Zotz S, Torzewski M, Lackner K, Munzel T, Blankenberg S, AtheroGene Investigators (2007) Glutathione peroxidase-1 activity, atherosclerotic burden, and cardiovascular prognosis. Am J Cardiol 99:808–812PubMedCrossRefGoogle Scholar
  78. Evans D, Beil FU (2003) The association of the R219K polymorphism in the ATP-binding cassette transporter 1 (ABCA1) gene with coronary heart disease and hyperlipidaemia. J Mol Med 81:264–270PubMedCrossRefGoogle Scholar
  79. Fan M, Raitakari OT, Kähönen M, Juonala M, Hutri-Kähönen N, Marniemi J, Rontu R, Pörsti I, Viikari J, Lehtimäki T (2007a) CYBA C242T gene polymorphism and flow-mediated vasodilation in a population of young adults: the Cardiovascular Risk in Young Finns Study. J Hypertens 25:1381–1387PubMedCrossRefGoogle Scholar
  80. Fan YM, Lehtimäki T, Rontu R, Ilveskoski E, Goebeler S, Kajander O, Mikkelsson J, Viiri LE, Perola M, Karhunen PJ (2007b) The hepatic lipase gene C-480T polymorphism in the development of early coronary atherosclerosis: the Helsinki Sudden Death Study. Eur J Clin Invest 37:472–477PubMedCrossRefGoogle Scholar
  81. Fatini C, Sofi F, Gensini F, Sticchi E, Lari B, Pratesi G, Pulli R, Dorigo W, Pratesi C, Gensini GF, Abbate R (2004) Influence of eNOS gene polymorphisms on carotid atherosclerosis. Eur J Vasc Endovasc Surg 27:540–544PubMedCrossRefGoogle Scholar
  82. Flex A, Gaetani E, Pola R, Santoliquido A, Aloi F, Papaleo P, Dal Lago A, Pola E, Serricchio M, Tondi P, Pola P (2002) The −174 G/C polymorphism of the interleukin (IL)-6 gene promoter is associated with peripheral artery occlusive disease. Eur J Vasc Endovasc Surg 24:264–268PubMedCrossRefGoogle Scholar
  83. Forgione MA, Weiss N, Heydrick S, Cap A, Klings ES, Bierl C, Eberhardt RT, Farber HW, Loscalzo J (2002) Cellular glutathione peroxidase deficiency and endothelial dysfunction. Am J Physiol Heart Circ Physiol 282:H1255–H1261PubMedGoogle Scholar
  84. Fortunato G, Rubba P, Panico S, Trono D, Tinto N, Mazzaccara C, De Michele M, Iannuzzi A, Vitale DF, Salvatore F, Sacchetti L (2003) A paraoxonase gene polymorphism, PON 1 (55), as an independent risk factor for increased carotid intima-media thickness in middle-aged women. Atherosclerosis 167:141–148PubMedCrossRefGoogle Scholar
  85. Frantz S, Ertl G, Bauersachs J (2007) Mechanisms of disease: Toll-like receptors in cardiovascular disease. Nat Clin Pract Cardiovasc Med 4:444–454PubMedCrossRefGoogle Scholar
  86. Freiberg JJ, Tybjaerg-Hansen A, Sillesen H, Jensen GB, Nordestgaard BG (2008) Promotor polymorphisms in leukotriene C4 synthase and risk of ischemic cerebrovascular disease. Arterioscler Thromb Vasc Biol 28:990–996PubMedCrossRefGoogle Scholar
  87. Friedlander Y, Schwartz SM, Durst R, Meiner V, Robertson AS, Erez G, Leitersdorf E, Siscovick DS (2008) SREBP-2 and SCAP isoforms and risk of early onset myocardial infarction. Atherosclerosis 196:896–904PubMedCrossRefGoogle Scholar
  88. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111–113PubMedCrossRefGoogle Scholar
  89. Fujimoto H, Taguchi J, Imai Y, Ayabe S, Hashimoto H, Kobayashi H, Ogasawara K, Aizawa T, Yamakado M, Nagai R, Ohno M (2008) Manganese superoxide dismutase polymorphism affects the oxidized low-density lipoprotein-induced apoptosis of macrophages and coronary artery disease. Eur Heart J 29:1267–1274PubMedCrossRefGoogle Scholar
  90. Gaetani E, Flex A, Pola R, Papaleo P, De Martini D, Pola E, Aloi F, Flore R, Serricchio M, Gasbarrini A, Pola P (2002) The K469E polymorphism of the inter cellular adhesion molecule 1 (ICAM-1) gene is a risk factor for peripheral arterial occlusive disease. Blood Coagul Fibrinolysis 13:483–488PubMedCrossRefGoogle Scholar
  91. Garcia CK, Wilund K, Arca M, Zuliani G, Fellin R, Maioli M, Calandra S, Bertolini S, Cossu F, Grishin N, Barnes R, Cohen JC, Hobbs HH (2001) Autosomal recessive hypercholesterolemia caused by mutations in a putative LDL receptor adaptor protein. Science 292:1394–1398PubMedCrossRefGoogle Scholar
  92. Gardemann A, Mages P, Katz N, Tillmanns H, Haberbosch W (1999) The p22 phox A640G gene polymorphism but not the C242T gene variation is associated with coronary heart disease in younger individuals. Atherosclerosis 145:323Google Scholar
  93. Genest JJ Jr, McNamara JR, Salem DN, Wilson PW, Schaefer EJ, Malinow MR (1990) Plasma homocyst(e)ine levels in men with premature coronary artery disease. J Am Coll Cardiol 16:1114–1119PubMedGoogle Scholar
  94. Ghilardi G, Biondi ML, DeMonti M, Turri O, Guagnellini E, Scorza R (2002) Matrix metalloproteinase-1 and matrix metalloproteinase-3 gene promoter polymorphisms are associated with carotid artery stenosis. Stroke 33:2408–2412PubMedCrossRefGoogle Scholar
  95. Ghilardi G, Biondi ML, Turri O, Guagnellini E, Scorza R (2004) Internal carotid artery occlusive disease and polymorphisms of fractalkine receptor CX3CR1: a genetic risk factor. Stroke 35:1276–1279PubMedCrossRefGoogle Scholar
  96. Girelli D, Martinelli N, Trabetti E, Olivieri O, Cavallari U, Malerba G, Busti F, Friso S, Pizzolo F, Pignatti PF, Corrocher R (2007) ALOX5AP gene variants and risk of coronary artery disease: an angiography-based study. Eur J Hum Genet 15:959–966PubMedCrossRefGoogle Scholar
  97. Gnasso A, Motti C, Irace C, Di Gennaro I, Pujia A, Leto E, Ciamei M, Crivaro A, Bernardini S, Federici G, Cortese C (2002) The Arg allele in position 192 of PON1 is associated with carotid atherosclerosis in subjects with elevated HDLs. Atherosclerosis 164:289–295PubMedCrossRefGoogle Scholar
  98. Goldbourt U, Yaari S, Medalie JH (1997) Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality. A 21-year follow-up of 8,000 men. Arterioscler Thromb Vasc Biol 17:107–113PubMedGoogle Scholar
  99. González P, García-Castro M, Reguero JR, Batalla A, Ordóñez AG, Palop RL, Lozano I, Montes M, Alvarez V, Coto E (2006) The Pro279Leu variant in the transcription factor MEF2A is associated with myocardial infarction. J Med Genet 43:167–169PubMedCrossRefGoogle Scholar
  100. Gouni-Berthold I, Giannakidou E, Müller-Wieland D, Faust M, Kotzka J, Berthold HK, Krone W (2004) Association between the PPARalpha L162V polymorphism, plasma lipoprotein levels, and atherosclerotic disease in patients with diabetes mellitus type 2 and in nondiabetic controls. Am Heart J 147:1117–1124PubMedCrossRefGoogle Scholar
  101. Grainger DJ (2007) TGF-beta and atherosclerosis in man. Cardiovasc Res 74:213–222PubMedCrossRefGoogle Scholar
  102. Gretarsdottir S, Thorleifsson G, Reynisdottir ST, Manolescu A, Jonsdottir S, Jonsdottir T, Gudmundsdottir T, Bjarnadottir SM, Einarsson OB, Gudjonsdottir HM, Hawkins M, Gudmundsson G, Gudmundsdottir H, Andrason H, Gudmundsdottir AS, Sigurdardottir M, Chou TT, Nahmias J, Goss S, Sveinbjörnsdottir S, Valdimarsson EM, Jakobsson F, Agnarsson U, Gudnason V, Thorgeirsson G, Fingerle J, Gurney M, Gudbjartsson D, Frigge ML, Kong A, Stefansson K, Gulcher JR (2003) The gene encoding phosphodiesterase 4D confers risk of ischemic stroke. Nat Genet 35:131–138PubMedCrossRefGoogle Scholar
  103. Grönroos P, Raitakari OT, Kähönen M, Hutri-Kähönen N, Marniemi J, Viikari J, Lehtimäki T (2007) Influence of apolipoprotein E polymorphism on serum lipid and lipoprotein changes: a 21-year follow-up study from childhood to adulthood. The Cardiovascular Risk in Young Finns Study. Clin Chem Lab Med 45:592–598PubMedCrossRefGoogle Scholar
  104. Guerra R, Wang S, Grundy S, Cohen J (1997) A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol. Proc Natl Acad Sci USA 94:4532–4537PubMedCrossRefGoogle Scholar
  105. Guxens M, Tomás M, Elosua R, Aldasoro E, Segura A, Fiol M, Sala J, Vila J, Fullana M, Sentí M, Vega G, de la Rica M, Marrugat J, Investigadores del estudio IBERICA (2008) Association between paraoxonase-1 and paraoxonase-2 polymorphisms and the risk of acute myocardial infarction. Rev Esp Cardiol 61:269–275PubMedGoogle Scholar
  106. Guzik TJ, West NE, Black E, McDonald D, Ratnatunga C, Pillai R, Channon KM (2000) Functional effect of the C242T polymorphism in the NAD(P)H oxidase p22phox gene on vascular superoxide production in atherosclerosis. Circulation 102:1744–1747PubMedGoogle Scholar
  107. Hamanishi T, Furuta H, Kato H, Doi A, Tamai M, Shimomura H, Sakagashira S, Nishi M, Sasaki H, Sanke T, Nanjo K (2004) Functional variants in the glutathione peroxidase-1 (GPx-1) gene are associated with increased intima-media thickness of carotid arteries and risk of macrovascular diseases in Japanese type 2 diabetic patients. Diabetes 53:2455–2460PubMedCrossRefGoogle Scholar
  108. Hamsten A, Eriksson P (2008) Identifying the susceptibility genes for coronary artery disease: from hyperbole through doubt to cautious optimism. J Intern Med 263:538–552PubMedCrossRefGoogle Scholar
  109. Han Y, Xi S, Zhang X, Yan C, Yang Y, Kang J (2008) Association of connexin 37 gene polymorphisms with risk of coronary artery disease in northern Han Chinese. Cardiology 110:260–265PubMedCrossRefGoogle Scholar
  110. Hansson GK, Robertson AK, Söderberg-Nauclér C (2006) Inflammation and atherosclerosis. Annu Rev Pathol 1:297–329PubMedCrossRefGoogle Scholar
  111. Hayaishi-Okano R, Yamasaki Y, Kajimoto Y, Sakamoto K, Ohtoshi K, Katakami N, Kawamori D, Miyatsuka T, Hatazaki M, Hazama Y, Hori M (2003) Association of NAD(P)H oxidase p22 phox gene variation with advanced carotid atherosclerosis in Japanese type 2 diabetes. Diabetes Care 26:458–463PubMedCrossRefGoogle Scholar
  112. Heikkinen S, Auwerx J, Argmann CA (2007) PPARgamma in human and mouse physiology. Biochim Biophys Acta 1771:999–1013PubMedGoogle Scholar
  113. Helgadottir A, Manolescu A, Thorleifsson G, Gretarsdottir S, Jonsdottir H, Thorsteinsdottir U, Samani NJ, Gudmundsson G, Grant SF, Thorgeirsson G, Sveinbjornsdottir S, Valdimarsson EM, Matthiasson SE, Johannsson H, Gudmundsdottir O, Gurney ME, Sainz J, Thorhallsdottir M, Andresdottir M, Frigge ML, Topol EJ, Kong A, Gudnason V, Hakonarson H, Gulcher JR, Stefansson K (2004) The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat Genet 36:233–239PubMedCrossRefGoogle Scholar
  114. Helgadottir A, Manolescu A, Helgason A, Thorleifsson G, Thorsteinsdottir U, Gudbjartsson DF, Gretarsdottir S, Magnusson KP, Gudmundsson G, Hicks A, Jonsson T, Grant SF, Sainz J, O’Brien SJ, Sveinbjornsdottir S, Valdimarsson EM, Matthiasson SE, Levey AI, Abramson JL, Reilly MP, Vaccarino V, Wolfe ML, Gudnason V, Quyyumi AA, Topol EJ, Rader DJ, Thorgeirsson G, Gulcher JR, Hakonarson H, Kong A, Stefansson K (2006) A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction. Nat Genet 38:68–74PubMedCrossRefGoogle Scholar
  115. Helgadottir A, Thorleifsson G, Manolescu A, Gretarsdottir S, Blondal T, Jonasdottir A, Jonasdottir A, Sigurdsson A, Baker A, Palsson A, Masson G, Gudbjartsson DF, Magnusson KP, Andersen K, Levey AI, Backman VM, Matthiasdottir S, Jonsdottir T, Palsson S, Einarsdottir H, Gunnarsdottir S, Gylfason A, Vaccarino V, Hooper WC, Reilly MP, Granger CB, Austin H, Rader DJ, Shah SH, Quyyumi AA, Gulcher JR, Thorgeirsson G, Thorsteinsdottir U, Kong A, Stefansson K (2007) A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 316:1491–1493PubMedCrossRefGoogle Scholar
  116. Hinds DA, Seymour AB, Durham LK, Banerjee P, Ballinger DG, Milos PM, Cox DR, Thompson JF, Frazer KA (2004) Application of pooled genotyping to scan candidate regions for association with HDL cholesterol levels. Hum Genomics 1:421–434PubMedGoogle Scholar
  117. Hingorani AD, Liang CF, Fatibene J, Lyon A, Monteith S, Parsons A, Haydock S, Hopper RV, Stephens NG, O’Shaughnessy KM, Brown MJ (1999) A common variant of the endothelial nitric oxide synthase (Glu298→Asp) is a major risk factor for coronary artery disease in the UK. Circulation 100:1515–1520PubMedGoogle Scholar
  118. Hingorani AD, Shah T, Casas JP, Humphries SE, Talmud PJ (2009) C-reactive protein and coronary heart disease: predictive test or therapeutic target? Clin Chem 55:239–255PubMedCrossRefGoogle Scholar
  119. Hixson JE (1991) Apolipoprotein E polymorphisms affect atherosclerosis in young males. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Arterioscler Thromb 11:1237–1244PubMedGoogle Scholar
  120. Hofman MK, Princen HM, Zwinderman AH, Jukema JW (2005) Genetic variation in the rate-limiting enzyme in cholesterol catabolism (cholesterol 7alpha-hydroxylase) influences the progression of atherosclerosis and risk of new clinical events. Clin Sci (Lond) 108:539–545Google Scholar
  121. Horan PG, Allen AR, Patterson CC, Spence MS, McGlinchey PC, McKeown PP (2006) The connexin37 gene polymorphism and coronary artery disease in Ireland. Heart 92:395–396PubMedCrossRefGoogle Scholar
  122. Horne BD, Camp NJ, Carlquist JF, Muhlestein JB, Kolek MJ, Nicholas ZP, Anderson JL (2007) Multiple-polymorphism associations of 7 matrix metalloproteinase and tissue inhibitor metalloproteinase genes with myocardial infarction and angiographic coronary artery disease. Am Heart J 154:751–758PubMedCrossRefGoogle Scholar
  123. Hsu LA, Ko YL, Chang CJ, Hu CF, Wu S, Teng MS, Wang CL, Ho WJ, Ko YS, Hsu TS, Lee YS (2006) Genetic variations of apolipoprotein A5 gene is associated with the risk of coronary artery disease among Chinese in Taiwan. Atherosclerosis 185:143–149PubMedCrossRefGoogle Scholar
  124. Hu Y, Liu W, Huang R, Zhang XA (2006) A systematic review and meta-analysis of the relationship between lipoprotein lipase Asn291Ser variant and diseases. J Lipid Res 47:1908–1914PubMedCrossRefGoogle Scholar
  125. Hubácek JA, Berge KE, Stefková J, Pitha J, Skodová Z, Lánská V, Poledne R (2004) Polymorphisms in ABCG5 and ABCG8 transporters and plasma cholesterol levels. Physiol Res 53:395–401PubMedGoogle Scholar
  126. Humphries SE, Luong LA, Talmud PJ, Frick MH, Kesäniemi YA, Pasternack A, Taskinen MR, Syvänne M (1998) The 5A/6A polymorphism in the promoter of the stromelysin-1 (MMP-3) gene predicts progression of angiographically determined coronary artery disease in men in the LOCAT gemfibrozil study. Lopid Coronary Angiography Trial. Atherosclerosis 139:49–56PubMedCrossRefGoogle Scholar
  127. Humphries SE, Ridker PM, Talmud PJ (2004) Genetic testing for cardiovascular disease susceptibility: a useful clinical management tool or possible misinformation? Arterioscler Thromb Vasc Biol 24:628–636PubMedCrossRefGoogle Scholar
  128. Huuskonen KH, Kunnas TA, Tanner MM, Mikkelsson J, Ilveskoski E, Karhunen PJ, Nikkari ST (2008) COX-2 gene promoter polymorphism and coronary artery disease in middle-aged men: the Helsinki sudden death study. Mediators Inflamm 2008:289453PubMedCrossRefGoogle Scholar
  129. Iacoviello L, Di Castelnuovo A, Gattone M, Pezzini A, Assanelli D, Lorenzet R, Del Zotto E, Colombo M, Napoleone E, Amore C, D’Orazio A, Padovani A, de Gaetano G, Giannuzzi P, Donati MB, IGIGI Investigators (2005) Polymorphisms of the interleukin-1beta gene affect the risk of myocardial infarction and ischemic stroke at young age and the response of mononuclear cells to stimulation in vitro. Arterioscler Thromb Vasc Biol 25:222–227PubMedGoogle Scholar
  130. Iakoubova OA, Tong CH, Rowland CM, Kirchgessner TG, Young BA, Arellano AR, Shiffman D, Sabatine MS, Campos H, Packard CJ, Pfeffer MA, White TJ, Braunwald E, Shepherd J, Devlin JJ, Sacks FM (2008) Association of the Trp719Arg polymorphism in kinesin-like protein 6 with myocardial infarction and coronary heart disease in 2 prospective trials: the CARE and WOSCOPS trials. J Am Coll Cardiol 51:435–443PubMedCrossRefGoogle Scholar
  131. Imai Y, Morita H, Kurihara H, Sugiyama T, Kato N, Ebihara A, Hamada C, Kurihara Y, Shindo T, Oh-hashi Y, Yazaki Y (2000) Evidence for association between paraoxonase gene polymorphisms and atherosclerotic diseases. Atherosclerosis 149:435–442PubMedCrossRefGoogle Scholar
  132. Inoue N, Kawashima S, Kanazawa K, Yamada S, Akita H, Yokoyama M (1998) Polymorphism of the NADH/NADPH oxidase p22 phox gene in patients with coronary artery disease. Circulation 97:135–137PubMedGoogle Scholar
  133. Iovannisci DM, Lammer EJ, Steiner L, Cheng S, Mahoney LT, Davis PH, Lauer RM, Burns TL (2007) Association between a leukotriene C4 synthase gene promoter polymorphism and coronary artery calcium in young women: the Muscatine Study. Arterioscler Thromb Vasc Biol 27:394–399PubMedCrossRefGoogle Scholar
  134. Ireland H, Kunz G, Kyriakoulis K, Stubbs PJ, Lane DA (1997) Thrombomodulin gene mutations associated with myocardial infarction. Circulation 96:15–18PubMedGoogle Scholar
  135. Iwata E, Yamamoto I, Motomura T, Tsubakimori S, Nohnen S, Ohmoto M, Igarashi T, Azuma J (2003) The association of Pro12Ala polymorphism in PPARgamma2 with lower carotid artery IMT in Japanese. Diabetes Res Clin Pract 62:55–59PubMedCrossRefGoogle Scholar
  136. Jacquemin B, Antoniades C, Nyberg F, Plana E, Müller M, Greven S, Salomaa V, Sunyer J, Bellander T, Chalamandaris AG, Pistelli R, Koenig W, Peters A (2008) Common genetic polymorphisms and haplotypes of fibrinogen alpha, beta, and gamma chains affect fibrinogen levels and the response to proinflammatory stimulation in myocardial infarction survivors: the AIRGENE study. J Am Coll Cardiol 52:941–952PubMedCrossRefGoogle Scholar
  137. Jang Y, Chae JS, Hyun YJ, Koh SJ, Kim JY, Ko MJ, Rim SJ, Shin HJ, Ordovas JM, Lee JH (2007) The RANTES −403G>A promoter polymorphism in Korean men: association with serum RANTES concentration and coronary artery disease. Clin Sci (Lond) 113:349–356Google Scholar
  138. Jeerooburkhan N, Jones LC, Bujac S, Cooper JA, Miller GJ, Vallance P, Humphries SE, Hingorani AD (2001) Genetic and environmental determinants of plasma nitrogen oxides and risk of ischemic heart disease. Hypertension 38:1054–1061PubMedCrossRefGoogle Scholar
  139. Jormsjö S, Ye S, Moritz J, Walter DH, Dimmeler S, Zeiher AM, Henney A, Hamsten A, Eriksson P (2000) Allele-specific regulation of matrix metalloproteinase-12 gene activity is associated with coronary artery luminal dimensions in diabetic patients with manifest coronary artery disease. Circ Res 86:998–1003PubMedGoogle Scholar
  140. Jormsjö S, Whatling C, Walter DH, Zeiher AM, Hamsten A, Eriksson P (2001) Allele-specific regulation of matrix metalloproteinase-7 promoter activity is associated with coronary artery luminal dimensions among hypercholesterolemic patients. Arterioscler Thromb Vasc Biol 21:1834–1839PubMedCrossRefGoogle Scholar
  141. Jukema JW, van Boven AJ, Groenemeijer B, Zwinderman AH, Reiber JH, Bruschke AV, Henneman JA, Molhoek GP, Bruin T, Jansen H, Gagné E, Hayden MR, Kastelein JJ (1996) The Asp9 Asn mutation in the lipoprotein lipase gene is associated with increased progression of coronary atherosclerosis. REGRESS Study Group, Interuniversity Cardiology Institute, Utrecht, The Netherlands. Regression Growth Evaluation Statin Study. Circulation 94:1913–1918PubMedGoogle Scholar
  142. Juul K, Tybjaerg-Hansen A, Marklund S, Heegaard NH, Steffensen R, Sillesen H, Jensen G, Nordestgaard BG (2004) Genetically reduced antioxidative protection and increased ischemic heart disease risk: the Copenhagen City Heart Study. Circulation 109:59–65PubMedCrossRefGoogle Scholar
  143. Kajimoto K, Shioji K, Tago N, Tomoike H, Nonogi H, Goto Y, Iwai N (2005) Assessment of MEF2A mutations in myocardial infarction in Japanese patients. Circ J 69:1192–1195PubMedCrossRefGoogle Scholar
  144. Kakko S, Tamminen M, Päivänsalo M, Kauma H, Rantala AO, Lilja M, Reunanen A, Kesäniemi YA, Savolainen MJ (2000) Cholesteryl ester transfer protein gene polymorphisms are associated with carotid atherosclerosis in men. Eur J Clin Invest 30:18–25PubMedCrossRefGoogle Scholar
  145. Kakko S, Päivänsalo M, Koistinen P, Kesäniemi YA, Kinnula VL, Savolainen MJ (2003) The signal sequence polymorphism of the MnSOD gene is associated with the degree of carotid atherosclerosis. Atherosclerosis 168:147–152PubMedCrossRefGoogle Scholar
  146. Kaneda H, Ohno M, Taguchi J, Togo M, Hashimoto H, Ogasawara K, Aizawa T, Ishizaka N, Nagai R (2002) Heme oxygenase-1 gene promoter polymorphism is associated with coronary artery disease in Japanese patients with coronary risk factors. Arterioscler Thromb Vasc Biol 22:1680–1685PubMedCrossRefGoogle Scholar
  147. Karathanasis SK, Ferris E, Haddad IA (1987) DNA inversion within the apolipoproteins AI/CIII/AIV-encoding gene cluster of certain patients with premature atherosclerosis. Proc Natl Acad Sci USA 84:7198–7202PubMedCrossRefGoogle Scholar
  148. Kawashima S, Yokoyama M (2004) Dysfunction of endothelial nitric oxide synthase and atherosclerosis. Arterioscler Thromb Vasc Biol 24:998–1005PubMedCrossRefGoogle Scholar
  149. Kelly PJ, Rosand J, Kistler JP, Shih VE, Silveira S, Plomaritoglou A, Furie KL (2002) Homocysteine, MTHFR 677C→T polymorphism, and risk of ischemic stroke: results of a meta-analysis. Neurology 59:529–536PubMedGoogle Scholar
  150. Keso T, Perola M, Laippala P, Ilveskoski E, Kunnas TA, Mikkelsson J, Penttilä A, Hurme M, Karhunen PJ (2001) Polymorphisms within the tumor necrosis factor locus and prevalence of coronary artery disease in middle-aged men. Atherosclerosis 154:691–697PubMedCrossRefGoogle Scholar
  151. Kiechl S, Lorenz E, Reindl M, Wiedermann CJ, Oberhollenzer F, Bonora E, Willeit J, Schwartz DA (2002) Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 347:185–192PubMedCrossRefGoogle Scholar
  152. Kim Y, Lee C (2006) The gene encoding transforming growth factor beta 1 confers risk of ischemic stroke and vascular dementia. Stroke 37:2845Google Scholar
  153. Kimpara T, Takeda A, Watanabe K, Itoyama Y, Ikawa S, Watanabe M, Arai H, Sasaki H, Higuchi S, Okita N, Takase S, Saito H, Takahashi K, Shibahara S (1997) Microsatellite polymorphism in the human heme oxygenase-1 gene promoter and its application in association studies with Alzheimer and Parkinson disease. Hum Genet 100:145–147PubMedCrossRefGoogle Scholar
  154. Klerk M, Verhoef P, Clarke R, Blom HJ, Kok FJ, Schouten EG, MTHFR Studies Collaboration Group (2002) MTHFR 677C→T polymorphism and risk of coronary heart disease: a meta-analysis. JAMA 288:2023–2031PubMedCrossRefGoogle Scholar
  155. Kluijtmans LA, Whitehead AS (2001) Methylenetetrahydrofolate reductase genotypes and predisposition to atherothrombotic disease; evidence that all three MTHFR C677T genotypes confer different levels of risk. Eur Heart J 22:294–299PubMedCrossRefGoogle Scholar
  156. Knowles JW, Assimes TL, Li J, Quertermous T, Cooke JP (2007a) Genetic susceptibility to peripheral arterial disease: a dark corner in vascular biology. Arterioscler Thromb Vasc Biol 27:2068–2078PubMedCrossRefGoogle Scholar
  157. Knowles JW, Wang H, Itakura H, Southwick A, Myers RM, Iribarren C, Fortmann SP (2007b) Association of polymorphisms in platelet and hemostasis system genes with acute myocardial infarction. Am Heart J 154:1052–1058PubMedCrossRefGoogle Scholar
  158. Koch W, Kastrati A, Böttiger C, Mehilli J, von Beckerath N, Schömig A (2001) Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction. Atherosclerosis 159:137–144PubMedCrossRefGoogle Scholar
  159. Koch W, Hoppmann P, Mueller JC, Schomig A, Kastrati A (2006) Association of transforming growth factor-beta1 gene polymorphisms with myocardial infarction in patients with angiographically proven coronary heart disease. Arterioscler Thromb Vasc Biol 26:1119CrossRefGoogle Scholar
  160. Kohsaka S, Volcik KA, Folsom AR, Wu KK, Ballantyne CM, Willerson JT, Boerwinkle E (2008) Increased risk of incident stroke associated with the cyclooxygenase 2 (COX-2) G-765C polymorphism in African-Americans: the Atherosclerosis Risk in Communities Study. Atherosclerosis 196:926–930PubMedCrossRefGoogle Scholar
  161. Kretowski A, McFann K, Hokanson JE, Maahs D, Kinney G, Snell-Bergeon JK, Wadwa RP, Eckel RH, Ogden L, Garg S, Li J, Cheng S, Erlich HA, Rewers M (2007) Polymorphisms of the renin–angiotensin system genes predict progression of subclinical coronary atherosclerosis. Diabetes 56:863–871PubMedCrossRefGoogle Scholar
  162. Kristiansson K, Ilveskoski E, Lehtimäki T, Peltonen L, Perola M, Karhunen PJ (2008) Association analysis of allelic variants of USF1 in coronary atherosclerosis. Arterioscler Thromb Vasc Biol 28:983–989PubMedCrossRefGoogle Scholar
  163. Kronenberg F, Kronenberg MF, Kiechl S, Trenkwalder E, Santer P, Oberhollenzer F, Egger G, Utermann G, Willeit J (1999) Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis: prospective results from the Bruneck study. Circulation 100:1154–1160PubMedGoogle Scholar
  164. Kuhlenbäumer G, Berger K, Huge A, Lange E, Kessler C, John U, Funke H, Nabavi DG, Stögbauer F, Ringelstein EB, Stoll M (2006) Evaluation of single nucleotide polymorphisms in the phosphodiesterase 4D gene (PDE4D) and their association with ischaemic stroke in a large German cohort with ischaemic stroke. J Neurol Neurosurg Psychiatry 77:521–524PubMedCrossRefGoogle Scholar
  165. Kuivenhoven JA, Pritchard H, Hill J, Frohlich J, Assmann G, Kastelein J (1997) The molecular pathology of lecithin:cholesterol acyltransferase (LCAT) deficiency syndromes. J Lipid Res 38:191–205PubMedGoogle Scholar
  166. Kutty RK, Kutty G, Rodriguez IR, Chader GJ, Wiggert B (1994) Chromosomal localization of the human heme oxygenase genes: heme oxygenase-1 (HMOX1) maps to chromosome 22q12 and heme oxygenase-2 (HMOX2) maps to chromosome 16p13. Genomics 20:513–516PubMedCrossRefGoogle Scholar
  167. Kuzuya M, Iguchi A (2003) Role of matrix metalloproteinases in vascular remodeling. J Atheroscler Thromb 10:275–282PubMedGoogle Scholar
  168. Kyriakou T, Hodgkinson C, Pontefract DE, Iyengar S, Howell WM, Wong YK, Eriksson P, Ye S (2005) Genotypic effect of the −565C>T polymorphism in the ABCA1 gene promoter on ABCA1 expression and severity of atherosclerosis. Arterioscler Thromb Vasc Biol 25:418–423PubMedCrossRefGoogle Scholar
  169. Labrum R, Bevan S, Sitzer M, Lorenz M, Markus HS (2007) Toll receptor polymorphisms and carotid artery intima-media thickness. Stroke 38:1179–1184PubMedCrossRefGoogle Scholar
  170. Lagace TA, Curtis DE, Garuti R, McNutt MC, Park SW, Prather HB, Anderson NN, Ho YK, Hammer RE, Horton JD (2006) Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and in livers of parabiotic mice. J Clin Invest 116:2995–3005PubMedCrossRefGoogle Scholar
  171. Lahoz C, Schaefer EJ, Cupples LA, Wilson PW, Levy D, Osgood D, Parpos S, Pedro-Botet J, Daly JA, Ordovas JM (2001) Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study. Atherosclerosis 154:529–537PubMedCrossRefGoogle Scholar
  172. Laukkanen J, Ylä-Herttuala S (2002) Genes involved in atherosclerosis. Exp Nephrol 10:150–163PubMedCrossRefGoogle Scholar
  173. Lee CR, North KE, Bray MS, Couper DJ, Heiss G, Zeldin DC (2008) Cyclooxygenase polymorphisms and risk of cardiovascular events: the Atherosclerosis Risk in Communities (ARIC) study. Clin Pharmacol Ther 83:52–60PubMedCrossRefGoogle Scholar
  174. Leigh SE, Foster AH, Whittall RA, Hubbart CS, Humphries SE (2008) Update and analysis of the university college London low density lipoprotein receptor familial hypercholesterolemia database. Ann Hum Genet 72:485–498PubMedCrossRefGoogle Scholar
  175. Lewis SJ, Ebrahim S, Davey Smith G (2005) Meta-analysis of MTHFR 677C→T polymorphism and coronary heart disease: does totality of evidence support causal role for homocysteine and preventive potential of folate? BMJ 331:1053PubMedCrossRefGoogle Scholar
  176. Li YH, Chen JH, Wu HL, Shi GY, Huang HC, Chao TH, Tsai WC, Tsai LM, Guo HR, Wu WS, Chen ZC (2000) G-33A mutation in the promoter region of thrombomodulin gene and its association with coronary artery disease and plasma soluble thrombomodulin levels. Am J Cardiol 85:8–12PubMedCrossRefGoogle Scholar
  177. Li YH, Chen CH, Yeh PS, Lin HJ, Chang BI, Lin JC, Guo HR, Wu HL, Shi GY, Lai ML, Chen JH (2001) Functional mutation in the promoter region of thrombomodulin gene in relation to carotid atherosclerosis. Atherosclerosis 154:713–719PubMedCrossRefGoogle Scholar
  178. Li J, Tumanut C, Gavigan JA, Huang WJ, Hampton EN, Tumanut R, Suen KF, Trauger JW, Spraggon G, Lesley SA, Liau G, Yowe D, Harris JL (2007) Secreted PCSK9 promotes LDL receptor degradation independently of proteolytic activity. Biochem J 406:203–207PubMedCrossRefGoogle Scholar
  179. Libby P (2002) Inflammation in atherosclerosis. Nature 420:868–874PubMedCrossRefGoogle Scholar
  180. Libby P, Theroux P (2005) Pathophysiology of coronary artery disease. Circulation 111:3481–3488PubMedCrossRefGoogle Scholar
  181. Lieb W, Mayer B, König IR, Borwitzky I, Götz A, Kain S, Hengstenberg C, Linsel-Nitschke P, Fischer M, Döring A, Wichmann HE, Meitinger T, Kreutz R, Ziegler A, Schunkert H, Erdmann J (2008) Lack of association between the MEF2A gene and myocardial infarction. Circulation 117:185–191PubMedCrossRefGoogle Scholar
  182. Lindholm E, Melander O, Almgren P, Berglund G, Agardh CD, Groop L, Orho-Melander M (2006) Polymorphism in the MHC2TA gene is associated with features of the metabolic syndrome and cardiovascular mortality. PLoS ONE 1:e64PubMedCrossRefGoogle Scholar
  183. Listi F, Candore G, Lio D, Russo M, Colonna-Romano G, Caruso M, Hoffmann E, Caruso C (2005) Association between C1019T polymorphism of connexin37 and acute myocardial infarction: study in patients from Sicily. Int J Cardiol 102:269–271PubMedCrossRefGoogle Scholar
  184. Liu Y, Yuan Z, Liu Y, Zhang J, Yin P, Wang D, Wang Y, Kishimoto C, Ma A (2007) PPARgamma gene C161T substitution is associated with reduced risk of coronary artery disease and decreased proinflammatory cytokine expression. Am Heart J 154:718–724PubMedCrossRefGoogle Scholar
  185. Lõhmussaar E, Gschwendtner A, Mueller JC, Org T, Wichmann E, Hamann G, Meitinger T, Dichgans M (2005) ALOX5AP gene and the PDE4D gene in a central European population of stroke patients. Stroke 36:731–736PubMedCrossRefGoogle Scholar
  186. Luke MM, Kane JP, Liu DM, Rowland CM, Shiffman D, Cassano J, Catanese JJ, Pullinger CR, Leong DU, Arellano AR, Tong CH, Movsesyan I, Naya-Vigne J, Noordhof C, Feric NT, Malloy MJ, Topol EJ, Koschinsky ML, Devlin JJ, Ellis SG (2007) A polymorphism in the protease-like domain of apolipoprotein(a) is associated with severe coronary artery disease. Arterioscler Thromb Vasc Biol 27:2030–2036PubMedCrossRefGoogle Scholar
  187. Lusis AJ, Fogelman AM, Fonarow GC (2004a) Genetic basis of atherosclerosis: part I: new genes and pathways. Circulation 110:1868–1873PubMedCrossRefGoogle Scholar
  188. Lusis AJ, Mar R, Pajukanta P (2004b) Genetics of atherosclerosis. Annu Rev Genomics Hum Genet 5:189–218PubMedCrossRefGoogle Scholar
  189. Lutucuta S, Ballantyne CM, Elghannam H, Gotto AM Jr, Marian AJ (2001) Novel polymorphisms in promoter region of atp binding cassette transporter gene and plasma lipids, severity, progression, and regression of coronary atherosclerosis and response to therapy. Circ Res 88:969–973PubMedCrossRefGoogle Scholar
  190. Mäkelä R, Loimaala A, Nenonen A, Mercuri M, Vuori I, Huhtala H, Oja P, Bond G, Koivula T, Lehtimäki T (2008) The association of myeloperoxidase promoter polymorphism with carotid atherosclerosis is abolished in patients with type 2 diabetes. Clin Biochem 41:532–537PubMedCrossRefGoogle Scholar
  191. Mälarstig A, Eriksson P, Rose L, Diehl KA, Hamsten A, Ridker PM, Zee RY (2008) Genetic variants of tumor necrosis factor superfamily, member 4 (TNFSF4), and risk of incident atherothrombosis and venous thromboembolism. Clin Chem 54:833–840PubMedCrossRefGoogle Scholar
  192. Malin R, Loimaala A, Nenonen A, Mercuri M, Vuori I, Pasanen M, Oja P, Bond G, Koivula T, Lehtimäki T (2001) Relationship between high-density lipoprotein paraoxonase gene M/L55 polymorphism and carotid atherosclerosis differs in smoking and nonsmoking men. Metabolism 50:1095–1101PubMedCrossRefGoogle Scholar
  193. Malloy MJ, Kane JP (2001) A risk factor for atherosclerosis: triglyceride-rich lipoproteins. Adv Intern Med 47:111–136PubMedGoogle Scholar
  194. Mani A, Radhakrishnan J, Wang H, Mani A, Mani MA, Nelson-Williams C, Carew KS, Mane S, Najmabadi H, Wu D, Lifton RP (2007) LRP6 mutation in a family with early coronary disease and metabolic risk factors. Science 315:1278–1282PubMedCrossRefGoogle Scholar
  195. Mannila MN, Eriksson P, Lundman P, Samnegård A, Boquist S, Ericsson CG, Tornvall P, Hamsten A, Silveira A (2005) Contribution of haplotypes across the fibrinogen gene cluster to variation in risk of myocardial infarction. Thromb Haemost 93:570–577PubMedGoogle Scholar
  196. Mannila MN, Eriksson P, Leander K, Wiman B, de Faire U, Hamsten A, Silveira A (2007) The association between fibrinogen haplotypes and myocardial infarction in men is partly mediated through pleiotropic effects on the serum IL-6 concentration. J Intern Med 261:138–147PubMedCrossRefGoogle Scholar
  197. Markus HS, Labrum R, Bevan S, Reindl M, Egger G, Wiedermann CJ, Xu Q, Kiechl S, Willeit J (2006) Genetic and acquired inflammatory conditions are synergistically associated with early carotid atherosclerosis. Stroke 37:2253–2259PubMedCrossRefGoogle Scholar
  198. Marsden PA, Heng HH, Scherer SW, Stewart RJ, Hall AV, Shi XM, Tsui LC, Schappert KT (1993) Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem 268:17478–17488PubMedGoogle Scholar
  199. Martinelli N, Trabetti E, Bassi A, Girelli D, Friso S, Pizzolo F, Sandri M, Malerba G, Pignatti PF, Corrocher R, Olivieri O (2007) The −1131 T>C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: an angiographic study. Atherosclerosis 191:409–417PubMedCrossRefGoogle Scholar
  200. Martinelli N, Trabetti E, Pinotti M, Olivieri O, Sandri M, Friso S, Pizzolo F, Bozzini C, Caruso PP, Cavallari U, Cheng S, Pignatti PF, Bernardi F, Corrocher R, Girelli D (2008) Combined effect of hemostatic gene polymorphisms and the risk of myocardial infarction in patients with advanced coronary atherosclerosis. PLoS ONE 3:e1523PubMedCrossRefGoogle Scholar
  201. Marx N, Duez H, Fruchart JC, Staels B (2004) Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells. Circ Res 94:1168–1178PubMedCrossRefGoogle Scholar
  202. Matsumoto Y, Daida H, Watanabe Y, Sunayama S, Mokuno H, Yokoi H, Yamaguchi H (1998) High level of lipoprotein(a) is a strong predictor for progression of coronary artery disease. J Atheroscler Thromb 5:47–53PubMedGoogle Scholar
  203. Matsunaga T, Hiasa Y, Yanagi H, Maeda T, Hattori N, Yamakawa K, Yamanouchi Y, Tanaka I, Obara T, Hamaguchi H (1991) Apolipoprotein A-I deficiency due to a codon 84 nonsense mutation of the apolipoprotein A-I gene. Proc Natl Acad Sci USA 88:2793–2797PubMedCrossRefGoogle Scholar
  204. Mayer M (2000) Association of serum bilirubin concentration with risk of coronary artery disease. Clin Chem 46:1723–1727PubMedGoogle Scholar
  205. Maznyczka A, Braund P, Mangino M, Samani NJ (2008) Arachidonate 5-lipoxygenase (5-LO) promoter genotype and risk of myocardial infarction: a case-control study. Atherosclerosis 199:328–332PubMedCrossRefGoogle Scholar
  206. McCaskie PA, Beilby JP, Chapman CM, Hung J, McQuillan BM, Thompson PL, Palmer LJ (2007) Cholesteryl ester transfer protein gene haplotypes, plasma high-density lipoprotein levels and the risk of coronary heart disease. Hum Genet 121:401–411PubMedCrossRefGoogle Scholar
  207. McDermott DH, Yang Q, Kathiresan S, Cupples LA, Massaro JM, Keaney JF Jr, Larson MG, Vasan RS, Hirschhorn JN, O’Donnell CJ, Murphy PM, Benjamin EJ (2005) CCL2 polymorphisms are associated with serum monocyte chemoattractant protein-1 levels and myocardial infarction in the Framingham Heart Study. Circulation 112:1113–1120PubMedCrossRefGoogle Scholar
  208. McPherson R, Pertsemlidis A, Kavaslar N, Stewart A, Roberts R, Cox DR, Hinds DA, Pennacchio LA, Tybjaerg-Hansen A, Folsom AR, Boerwinkle E, Hobbs HH, Cohen JC (2007) A common allele on chromosome 9 associated with coronary heart disease. Science 316:1488–1491PubMedCrossRefGoogle Scholar
  209. Meiner V, Friedlander Y, Milo H, Sharon N, Ben-Avi L, Shpitzen S, Leitersdorf E, Siscovick DS, Schwartz SM (2008) Cholesteryl ester transfer protein (CETP) genetic variation and early onset of non-fatal myocardial infarction. Ann Hum Genet 72:732–741PubMedCrossRefGoogle Scholar
  210. Meschia JF, Brott TG, Brown RD Jr, Crook R, Worrall BB, Kissela B, Brown WM, Rich SS, Case LD, Evans EW, Hague S, Singleton A, Hardy J, SWISS Study Group; ISGS Study Group; MSGD Study Group (2005) Phosphodiesterase 4D and 5-lipoxygenase activating protein in ischemic stroke. Ann Neurol 58:351–361PubMedCrossRefGoogle Scholar
  211. Miles C, Wayne M (2008) Quantitative trait locus (QTL) analysis. Nat Educ 1:1Google Scholar
  212. Miwa Y, Takiuchi S, Kamide K, Yoshii M, Horio T, Tanaka C, Banno M, Miyata T, Sasaguri T, Kawano Y (2004) Identification of gene polymorphism in lipocalin-type prostaglandin D synthase and its association with carotid atherosclerosis in Japanese hypertensive patients. Biochem Biophys Res Commun 322:428–433PubMedCrossRefGoogle Scholar
  213. Moatti D, Faure S, Fumeron F, Mel-W Amara, Seknadji P, McDermott DH, Debré P, Aumont MC, Murphy PM, de Prost D, Combadière C (2001) Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease. Blood 97:1925–1928PubMedCrossRefGoogle Scholar
  214. Muendlein A, Saely CH, Marte T, Schmid F, Koch L, Rein P, Langer P, Aczel S, Drexel H (2008) Synergistic effects of the apolipoprotein E epsilon3/epsilon2/epsilon4, the cholesteryl ester transfer protein TaqIB, and the apolipoprotein C3 −482 C>T polymorphisms on their association with coronary artery disease. Atherosclerosis 199:179–186PubMedCrossRefGoogle Scholar
  215. Nam BH, Kannel WB, D’Agostino RB (2006) Search for an optimal atherogenic lipid risk profile: from the Framingham Study. Am J Cardiol 97:372–375PubMedCrossRefGoogle Scholar
  216. Naoumova RP, Tosi I, Patel D, Neuwirth C, Horswell SD, Marais AD, van Heyningen C, Soutar AK (2005) Severe hypercholesterolemia in four British families with the D374Y mutation in the PCSK9 gene: long-term follow-up and treatment response. Arterioscler Thromb Vasc Biol 25:2654–2660PubMedCrossRefGoogle Scholar
  217. Nasti S, Spallarossa P, Altieri P, Garibaldi S, Fabbi P, Polito L, Bacino L, Brunelli M, Brunelli C, Barsotti A, Ghigliotti G (2006) C242T polymorphism in CYBA gene (p22phox) and risk of coronary artery disease in a population of Caucasian Italians. Dis Markers 22:167–173PubMedGoogle Scholar
  218. NBT-HA Agerholm-Larsen B (2000) ACE gene polymorphism in cardiovascular disease: meta-analyses of small and large studies in whites. Arterioscler Thromb Vasc Biol 20:484–492Google Scholar
  219. Nemoto M, Nishimura R, Sasaki T, Hiki Y, Miyashita Y, Nishioka M, Fujimoto K, Sakuma T, Ohashi T, Fukuda K, Eto Y, Tajima N (2007) Genetic association of glutathione peroxidase-1 with coronary artery calcification in type 2 diabetes: a case control study with multi-slice computed tomography. Cardiovasc Diabetol 6:23PubMedCrossRefGoogle Scholar
  220. Ng CJ, Wadleigh DJ, Gangopadhyay A, Hama S, Grijalva VR, Navab M, Fogelman AM, Reddy ST (2001) Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein. J Biol Chem 276:44444–44449PubMedCrossRefGoogle Scholar
  221. Nicholls SJ, Hazen SL (2005) Myeloperoxidase and cardiovascular disease. Arterioscler Thromb Vasc Biol 25:1102–1111PubMedCrossRefGoogle Scholar
  222. Niessner A, Marculescu R, Haschemi A, Endler G, Zorn G, Weyand CM, Maurer G, Mannhalter C, Wojta J, Wagner O, Huber K (2005) Opposite effects of CX3CR1 receptor polymorphisms V249I and T280M on the development of acute coronary syndrome. A possible implication of fractalkine in inflammatory activation. Thromb Haemost 93:949–954PubMedGoogle Scholar
  223. Nikpoor B, Turecki G, Fournier C, Theroux P, Rouleau GA (2001) A functional myeloperoxidase polymorphic variant is associated with coronary artery disease in French–Canadians. Am Heart J 142:336–339PubMedCrossRefGoogle Scholar
  224. Nilsson-Ardnor S, Wiklund PG, Lindgren P, Nilsson AK, Janunger T, Escher SA, Hallbeck B, Stegmayr B, Asplund K, Holmberg D (2005) Linkage of ischemic stroke to the PDE4D region on 5q in a Swedish population. Stroke 36:1666–1671PubMedCrossRefGoogle Scholar
  225. Norata GD, Garlaschelli K, Ongari M, Raselli S, Grigore L, Benvenuto F, Maggi FM, Catapano AL (2005) Effect of the Toll-like receptor 4 (TLR-4) variants on intima-media thickness and monocyte-derived macrophage response to LPS. J Intern Med 258:21–27PubMedCrossRefGoogle Scholar
  226. Oberkofler H, Iglseder B, Klein K, Unger J, Haltmayer M, Krempler F, Paulweber B, Patsch W (2005) Associations of the UCP2 gene locus with asymptomatic carotid atherosclerosis in middle-aged women. Arterioscler Thromb Vasc Biol 25:604–610PubMedCrossRefGoogle Scholar
  227. Oda K, Tanaka N, Arai T, Araki J, Song Y, Zhang L, Kuchiba A, Hosoi T, Shirasawa T, Muramatsu M, Sawabe M (2007) Polymorphisms in pro- and anti-inflammatory cytokine genes and susceptibility to atherosclerosis: a pathological study of 1,503 consecutive autopsy cases. Hum Mol Genet 16:592–599PubMedCrossRefGoogle Scholar
  228. Ohashi M, Runge MS, Faraci FM, Heistad DD (2006) MnSOD deficiency increases endothelial dysfunction in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 26:2331–2336PubMedCrossRefGoogle Scholar
  229. Okubo M, Horinishi A, Saito M, Ebara T, Endo Y, Kaku K, Murase T, Eto M (2007) A novel complex deletion–insertion mutation mediated by Alu repetitive elements leads to lipoprotein lipase deficiency. Mol Genet Metab 92:229–233PubMedCrossRefGoogle Scholar
  230. Oliveira SA, Mansur AP, Ribeiro CC, Ramires JA, Annichino-Bizzacchi JM (2004) PON1 M/L55 mutation protects high-risk patients against coronary artery disease. Int J Cardiol 94:73–77PubMedCrossRefGoogle Scholar
  231. Olivieri O, Stranieri C, Bassi A, Zaia B, Girelli D, Pizzolo F, Trabetti E, Cheng S, Grow MA, Pignatti PF, Corrocher R (2002) ApoC-III gene polymorphisms and risk of coronary artery disease. J Lipid Res 43:1450–1457PubMedCrossRefGoogle Scholar
  232. Onalan O, Balta G, Oto A, Kabakci G, Tokgozoglu L, Aytemir K, Altay C, Gurgey A, Nazli N (2008) Plasminogen activator inhibitor-1 4G/4G genotype is associated with myocardial infarction but not with stable coronary artery disease. J Thromb Thrombolysis 26:211–217PubMedCrossRefGoogle Scholar
  233. Oram JF, Lawn RM (2001) ABCA1. The gatekeeper for eliminating excess tissue cholesterol. J Lipid Res 42:1173–1179PubMedGoogle Scholar
  234. Orbe J, Beloqui O, Rodriguez JA, Belzunce MS, Roncal C, Páramo JA (2006) Protective effect of the G-765C COX-2 polymorphism on subclinical atherosclerosis and inflammatory markers in asymptomatic subjects with cardiovascular risk factors. Clin Chim Acta 368:138–143PubMedCrossRefGoogle Scholar
  235. Ordovas JM, Cassidy DK, Civeira K, Bisgaier CL, Schaefer EJ (1989) Familial apolipoprotein A-I, C-III, and A-IV deficiency and premature atherosclerosis due to deletion of a gene complex on chromosome 11. J Biol Chem 264:16339–16345PubMedGoogle Scholar
  236. Ordovas JM, Cupples LA, Corella D, Otvos JD, Osgood D, Martinez A, Lahoz C, Coltell O, Wilson PW, Schaefer EJ (2000) Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study. Arterioscler Thromb Vasc Biol 20:1323–1329PubMedGoogle Scholar
  237. Ozaki K, Ohnishi Y, Iida A, Sekine A, Yamada R, Tsunoda T, Sato H, Sato H, Hori M, Nakamura Y, Tanaka T (2002) Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction. Nat Genet 32:650–654PubMedCrossRefGoogle Scholar
  238. Pajukanta P, Lilja HE, Sinsheimer JS, Cantor RM, Lusis AJ, Gentile M, Duan XJ, Soro-Paavonen A, Naukkarinen J, Saarela J, Laakso M, Ehnholm C, Taskinen MR, Peltonen L (2004) Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1). Nat Genet 36:371–376PubMedCrossRefGoogle Scholar
  239. Paradossi U, Ciofini E, Clerico A, Botto N, Biagini A, Colombo MG (2004) Endothelial function and carotid intima-media thickness in young healthy subjects among endothelial nitric oxide synthase Glu298→Asp and T-786→C polymorphisms. Stroke 35:1305–1309PubMedCrossRefGoogle Scholar
  240. Park HY, Nabika T, Jang Y, Kwon HM, Cho SY, Masuda J (2002) Association of G-33A polymorphism in the thrombomodulin gene with myocardial infarction in Koreans. Hypertens Res 25:389–394PubMedCrossRefGoogle Scholar
  241. Pasdar A, Ross-Adams H, Cumming A, Cheung J, Whalley L, St Clair D, MacLeod MJ (2006) Paraoxonase gene polymorphisms and haplotype analysis in a stroke population. BMC Med Genet 7:28PubMedCrossRefGoogle Scholar
  242. Pati U, Pati N (2000) Lipoprotein(a), atherosclerosis, and apolipoprotein(a) gene polymorphism. Mol Genet Metab 71:87–92PubMedCrossRefGoogle Scholar
  243. Pisciotta L, Priore Oliva C, Pes GM, Di Scala L, Bellocchio A, Fresa R, Cantafora A, Arca M, Calandra S, Bertolini S (2006) Autosomal recessive hypercholesterolemia (ARH) and homozygous familial hypercholesterolemia (FH): a phenotypic comparison. Atherosclerosis 188:398–405PubMedCrossRefGoogle Scholar
  244. Pocathikorn A, Granath B, Thiry E, Van Leuven F, Taylor R, Mamotte C (2003) Influence of exonic polymorphisms in the gene for LDL receptor-related protein (LRP) on risk of coronary artery disease. Atherosclerosis 168:115–121PubMedCrossRefGoogle Scholar
  245. Poirier O, Mao C, Mallet C, Nicaud V, Herrmann SM, Evans A, Ruidavets JB, Arveiler D, Luc G, Tiret L, Soubrier F, Cambien F (1999) Polymorphisms of the endothelial nitric oxide synthase gene—no consistent association with myocardial infarction in the ECTIM study. Eur J Clin Invest 29:284–290PubMedCrossRefGoogle Scholar
  246. PROCARDIS Consortium (2004) A trio family study showing association of the lymphotoxin-alpha N26 (804A) allele with coronary artery disease. Eur J Hum Genet 12:770–774CrossRefGoogle Scholar
  247. Pullinger CR, Eng C, Salen G, Shefer S, Batta AK, Erickson SK, Verhagen A, Rivera CR, Mulvihill SJ, Malloy MJ, Kane JP (2002) Human cholesterol 7alpha-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype. J Clin Invest 110:109–117PubMedGoogle Scholar
  248. Rader DJ, Daugherty A (2008) Translating molecular discoveries into new therapies for atherosclerosis. Nature 451:904–913PubMedCrossRefGoogle Scholar
  249. Rader DJ, Ikewaki K, Duverger N, Feuerstein I, Zech L, Connor W, Brewer HB Jr (1993) Very low high-density lipoproteins without coronary atherosclerosis. Lancet 342:1455–1458PubMedCrossRefGoogle Scholar
  250. Rai TS, Khullar M, Sehrawat BS, Ahuja M, Sharma PK, Vijayvergiya R, Grover A (2008) Synergistic effect between apolipoprotein E and apolipoprotein A1 gene polymorphisms in the risk for coronary artery disease. Mol Cell Biochem 313:139–146PubMedCrossRefGoogle Scholar
  251. Ranade K, Kirchgessner TG, Iakoubova OA, Devlin JJ, DelMonte T, Vishnupad P, Hui L, Tsuchihashi Z, Sacks FM, Sabatine MS, Braunwald E, White TJ, Shaw PM, Dracopoli NC (2005) Evaluation of the paraoxonases as candidate genes for stroke: Gln192Arg polymorphism in the paraoxonase 1 gene is associated with increased risk of stroke. Stroke 36:2346–2350PubMedCrossRefGoogle Scholar
  252. Rauramaa R, Väisänen SB, Luong LA, Schmidt-Trücksäss A, Penttilä IM, Bouchard C, Töyry J, Humphries SE (2000) Stromelysin-1 and interleukin-6 gene promoter polymorphisms are determinants of asymptomatic carotid artery atherosclerosis. Arterioscler Thromb Vasc Biol 20:2657–2662PubMedGoogle Scholar
  253. Reddy ST, Wadleigh DJ, Grijalva V, Ng C, Hama S, Gangopadhyay A, Shih DM, Lusis AJ, Navab M, Fogelman AM (2001) Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids. Arterioscler Thromb Vasc Biol 21:542–547PubMedGoogle Scholar
  254. Reddy ST, Devarajan A, Bourquard N, Shih D, Fogelman AM (2008) Is it just paraoxonase 1 or are other members of the paraoxonase gene family implicated in atherosclerosis? Curr Opin Lipidol 19:405–408PubMedCrossRefGoogle Scholar
  255. Reguero JR, Cubero GI, Batalla A, Alvarez V, Hevia S, Cortina A, Coto E (1998) Apolipoprotein A1 gene polymorphisms and risk of early coronary disease. Cardiology 90:231–235PubMedCrossRefGoogle Scholar
  256. Reiner AP, Carlson CS, Jenny NS, Durda JP, Siscovick DS, Nickerson DA, Tracy RP (2007) USF1 gene variants, cardiovascular risk, and mortality in European Americans: analysis of two US cohort studies. Arterioscler Thromb Vasc Biol 27:2736–2742PubMedCrossRefGoogle Scholar
  257. Reitz C, Berger K, de Maat MP, Stoll M, Friedrichs F, Kardys I, Witteman JC, Breteler MM (2007) CRP gene haplotypes, serum CRP, and cerebral small-vessel disease: the Rotterdam Scan Study and the MEMO Study. Stroke 38:2356–2359PubMedCrossRefGoogle Scholar
  258. Rhee EJ, Kwon CH, Lee WY, Kim SY, Jung CH, Kim BJ, Sung KC, Kim BS, Oh KW, Kang JH, Park SW, Kim SW, Lee MH, Park JR (2007) No association of Pro12Ala polymorphism of PPAR-gamma gene with coronary artery disease in Korean subjects. Circ J 71:338–342PubMedCrossRefGoogle Scholar
  259. Rifai N, Ridker PM (2001) High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease. Clin Chem 47:403–411PubMedGoogle Scholar
  260. Rifai N, Ma J, Sacks FM, Ridker PM, Hernandez WJ, Stampfer MJ, Marcovina SM (2004) Apolipoprotein(a) size and lipoprotein(a) concentration and future risk of angina pectoris with evidence of severe coronary atherosclerosis in men: the Physicians’ Health Study. Clin Chem 50:1364–1371PubMedCrossRefGoogle Scholar
  261. Ritsch A, Sonderegger G, Sandhofer A, Stanzl U, Tancevski I, Eller P, Schgoer W, Wehinger A, Mueller T, Haltmayer M, Patsch JR (2007) Scavenger receptor class B type I polymorphisms and peripheral arterial disease. Metabolism 56:1135–1141PubMedCrossRefGoogle Scholar
  262. Robinet P, Védie B, Chironi G, Gariépy J, Simon A, Moatti N, Paul JL (2003) Characterization of polymorphic structure of SREBP-2 gene: role in atherosclerosis. Atherosclerosis 168:381–387PubMedCrossRefGoogle Scholar
  263. Rodríguez-Esparragón F, Rodríguez-Pérez JC, Hernández-Trujillo Y, Macías-Reyes A, Medina A, Caballero A, Ferrario CM (2005) Allelic variants of the human scavenger receptor class B type 1 and paraoxonase 1 on coronary heart disease: genotype–phenotype correlations. Arterioscler Thromb Vasc Biol 25:854–860PubMedCrossRefGoogle Scholar
  264. Roy H, Bhardwaj S, Ylä-Herttuala S (2006a) Biology of vascular endothelial growth factors. FEBS Lett 580:2879–2887PubMedCrossRefGoogle Scholar
  265. Roy H, Bhardwaj S, Babu M, Kokina I, Uotila S, Ahtialansaari T, Laitinen T, Hakumaki J, Laakso M, Herzig KH, Ylä-Herttuala S (2006b) VEGF-A, VEGF-D, VEGF receptor-1, VEGF receptor-2, NF-kappaB, and RAGE in atherosclerotic lesions of diabetic Watanabe heritable hyperlipidemic rabbits. FASEB J 20:2159–2161PubMedCrossRefGoogle Scholar
  266. Rundek T, Elkind MS, Pittman J, Boden-Albala B, Martin S, Humphries SE, Juo SH, Sacco RL (2002) Carotid intima-media thickness is associated with allelic variants of stromelysin-1, interleukin-6, and hepatic lipase genes: the Northern Manhattan Prospective Cohort Study. Stroke 33:1420–1423PubMedCrossRefGoogle Scholar
  267. Rust S, Rosier M, Funke H, Real J, Amoura Z, Piette JC, Deleuze JF, Brewer HB, Duverger N, Denefle P, Assmann G (1999) Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet 22:352–355PubMedCrossRefGoogle Scholar
  268. Saha N, Sanghera DK, Kamboh MI (1999) The p22 phox polymorphism C242T is not associated with CHD risk in Asian Indians and Chinese. Eur J Clin Invest 29:999–1002PubMedCrossRefGoogle Scholar
  269. Samani NJ, Erdmann J, Hall AS, Hengstenberg C, Mangino M, Mayer B, Dixon RJ, Meitinger T, Braund P, Wichmann HE, Barrett JH, König IR, Stevens SE, Szymczak S, Tregouet DA, Iles MM, Pahlke F, Pollard H, Lieb W, Cambien F, Fischer M, Ouwehand W, Blankenberg S, Balmforth AJ, Baessler A, Ball SG, Strom TM, Braenne I, Gieger C, Deloukas P, Tobin MD, Ziegler A, Thompson JR, Schunkert H, WTCCC, the Cardiogenics Consortium (2007) Genomewide association analysis of coronary artery disease. N Engl J Med 357:443–453PubMedCrossRefGoogle Scholar
  270. Samani NJ, Braund PS, Erdmann J, Götz A, Tomaszewski M, Linsel-Nitschke P, Hajat C, Mangino M, Hengstenberg C, Stark K, Ziegler A, Caulfield M, Burton PR, Schunkert H, Tobin MD (2008) The novel genetic variant predisposing to coronary artery disease in the region of the PSRC1 and CELSR2 genes on chromosome 1 associates with serum cholesterol. J Mol Med 86:1233–1241PubMedCrossRefGoogle Scholar
  271. Samnegård A, Silveira A, Lundman P, Boquist S, Odeberg J, Hulthe J, McPheat W, Tornvall P, Bergstrand L, Ericsson CG, Hamsten A, Eriksson P (2005) Serum matrix metalloproteinase-3 concentration is influenced by MMP-3 −1612 5A/6A promoter genotype and associated with myocardial infarction. J Intern Med 258:411–419PubMedCrossRefGoogle Scholar
  272. Sandhofer A, Iglseder B, Kaser S, Morè E, Paulweber B, Patsch JR (2008) The influence of two variants in the adenosine triphosphate-binding cassette transporter 1 gene on plasma lipids and carotid atherosclerosis. Metabolism 57:1398–1404PubMedCrossRefGoogle Scholar
  273. Sasaoka T, Kimura A, Hohta SA, Fukuda N, Kurosawa T, Izumi T (2001) Polymorphisms in the platelet-endothelial cell adhesion molecule-1 (PECAM-1) gene, Asn563Ser and Gly670Arg, associated with myocardial infarction in the Japanese. Ann N Y Acad Sci 947:259–269PubMedCrossRefGoogle Scholar
  274. Schulz S, Birkenmeier G, Schagdarsurengin U, Wenzel K, Müller-Werdan U, Rehfeld D, Süss T, Kabisch A, Werdan K, Gläser C (2003) Role of LDL receptor-related protein (LRP) in coronary atherosclerosis. Int J Cardiol 92:137–144PubMedCrossRefGoogle Scholar
  275. Sharda S, Gilmour A, Harris V, Singh VP, Sinha N, Tewari S, Ramesh V, Agrawal S, Mastana S (2008) Chemokine receptor 5 (CCR5) deletion polymorphism in North Indian patients with coronary artery disease. Int J Cardiol 124:254–258PubMedCrossRefGoogle Scholar
  276. Shiffman D, Rowland CM, Louie JZ, Luke MM, Bare LA, Bolonick JI, Young BA, Catanese JJ, Stiggins CF, Pullinger CR, Topol EJ, Malloy MJ, Kane JP, Ellis SG, Devlin JJ (2006) Gene variants of VAMP8 and HNRPUL1 are associated with early-onset myocardial infarction. Arterioscler Thromb Vasc Biol 26:1613–1618PubMedCrossRefGoogle Scholar
  277. Shiffman D, Chasman DI, Zee RY, Iakoubova OA, Louie JZ, Devlin JJ, Ridker PM (2008) A kinesin family member 6 variant is associated with coronary heart disease in the Women’s Health Study. J Am Coll Cardiol 51:444–448PubMedCrossRefGoogle Scholar
  278. Shimasaki Y, Yasue H, Yoshimura M, Nakayama M, Kugiyama K, Ogawa H, Harada E, Masuda T, Koyama W, Saito Y, Miyamoto Y, Ogawa Y, Nakao K (1998) Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction. J Am Coll Cardiol 31:1506–1510PubMedCrossRefGoogle Scholar
  279. Sie MP, Uitterlinden AG, Bos MJ, Arp PP, Breteler MM, Koudstaal PJ, Pols HA, Hofman A, van Duijn CM, Witteman JC (2006) TGF-beta 1 polymorphisms and risk of myocardial infarction and stroke: the Rotterdam Study. Stroke 37:2667–2671PubMedCrossRefGoogle Scholar
  280. Simionescu M (2007) Implications of early structural–functional changes in the endothelium for vascular disease. Arterioscler Thromb Vasc Biol 27:266–274PubMedCrossRefGoogle Scholar
  281. Singaraja RR, Brunham LR, Visscher H, Kastelein JJ, Hayden MR (2003) Efflux and atherosclerosis: the clinical and biochemical impact of variations in the ABCA1 gene. Arterioscler Thromb Vasc Biol 23:1322–1332PubMedCrossRefGoogle Scholar
  282. Slooter AJC, Bots ML, Havekes LM, del Sol AI, Cruts M, Grobbee DE, Hofman A, Van Broeckhoven C, Witteman JCM, van Duijn CM (2001) Apolipoprotein E and carotid artery atherosclerosis: the Rotterdam Study. Stroke 32:1947–1952PubMedCrossRefGoogle Scholar
  283. Soberman RJ, Christmas P (2003) The organization and consequences of eicosanoid signaling. J Clin Invest 111:1107–1113PubMedGoogle Scholar
  284. Soccio M, Toniato E, Evangelista V, Carluccio M, De Caterina R (2005) Oxidative stress and cardiovascular risk: the role of vascular NAD(P)H oxidase and its genetic variants. Eur J Clin Invest 35:305–314PubMedCrossRefGoogle Scholar
  285. Soutar AK, Naoumova RP, Traub LM (2003) Genetics, clinical phenotype, and molecular cell biology of autosomal recessive hypercholesterolemia. Arterioscler Thromb Vasc Biol 23:1963–1970PubMedCrossRefGoogle Scholar
  286. Stephens JW, Bain SC, Humphries SE (2008) Gene–environment interaction and oxidative stress in cardiovascular disease. Atherosclerosis 200:229–238PubMedCrossRefGoogle Scholar
  287. Swanberg M, Lidman O, Padyukov L, Eriksson P, Akesson E, Jagodic M, Lobell A, Khademi M, Börjesson O, Lindgren CM, Lundman P, Brookes AJ, Kere J, Luthman H, Alfredsson L, Hillert J, Klareskog L, Hamsten A, Piehl F, Olsson T (2005) MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction. Nat Genet 37:486–494PubMedCrossRefGoogle Scholar
  288. Syrris P, Carter ND, Metcalfe JC, Kemp PR, Grainger DJ, Kaski JC, Crossman DC, Francis SE, Gunn J, Jeffery S, Heathcote K (1998) Transforming growth factor-beta1 gene polymorphisms and coronary artery disease. Clin Sci (Lond) 95:667Google Scholar
  289. Tanaka C, Mannami T, Kamide K, Takiuchi S, Kokubo Y, Katsuya T, Kawano Y, Miyata T, Ogihara T, Tomoike H (2005) Single nucleotide polymorphisms in the interleukin-6 gene associated with blood pressure and atherosclerosis in a Japanese general population. Hypertens Res 28:35–41PubMedCrossRefGoogle Scholar
  290. Tang Y, Sun P, Guo D, Ferro A, Ji Y, Chen Q, Fan L (2006) A genetic variant c.553G > T in the apolipoprotein A5 gene is associated with an increased risk of coronary artery disease and altered triglyceride levels in a Chinese population. Atherosclerosis 185:433–437PubMedCrossRefGoogle Scholar
  291. Tang NP, Wang LS, Yang L, Gu HJ, Sun QM, Cong RH, Zhou B, Zhu HJ, Wang B (2008) Genetic variant in glutathione peroxidase 1 gene is associated with an increased risk of coronary artery disease in a Chinese population. Clin Chim Acta 395:89–93PubMedCrossRefGoogle Scholar
  292. Tegnér J, Skogsberg J, Björkegren J (2007) Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Multi-organ whole-genome measurements and reverse engineering to uncover gene networks underlying complex traits. J Lipid Res 48:267–277PubMedCrossRefGoogle Scholar
  293. Temelkova-Kurktschiev T, Hanefeld M, Chinetti G, Zawadzki C, Haulon S, Kubaszek A, Koehler C, Leonhardt W, Staels B, Laakso M (2004) Ala12Ala genotype of the peroxisome proliferator-activated receptor gamma2 protects against atherosclerosis. J Clin Endocrinol Metab 89:4238–4242PubMedCrossRefGoogle Scholar
  294. Thompson SR, McCaskie PA, Beilby JP, Hung J, Jennens M, Chapman C, Thompson P, Humphries SE (2007) IL18 haplotypes are associated with serum IL-18 concentrations in a population-based study and a cohort of individuals with premature coronary heart disease. Clin Chem 53:2078–2085PubMedCrossRefGoogle Scholar
  295. Topol EJ, McCarthy J, Gabriel S, Moliterno DJ, Rogers WJ, Newby LK, Freedman M, Metivier J, Cannata R, O’Donnell CJ, Kottke-Marchant K, Murugesan G, Plow EF, Stenina O, Daley GQ (2001) Single nucleotide polymorphisms in multiple novel thrombospondin genes may be associated with familial premature myocardial infarction. Circulation 104:2641–2644PubMedCrossRefGoogle Scholar
  296. Tregouet DA, Ricard S, Nicaud V, Arnould I, Soubigou S, Rosier M, Duverger N, Poirier O, Macé S, Kee F, Morrison C, Denèfle P, Tiret L, Evans A, Deleuze JF, Cambien F (2004) In-depth haplotype analysis of ABCA1 gene polymorphisms in relation to plasma ApoA1 levels and myocardial infarction. Arterioscler Thromb Vasc Biol 24:775–781PubMedCrossRefGoogle Scholar
  297. Trompet S, Pons D, De Craen AJ, Slagboom P, Shepherd J, Blauw GJ, Murphy MB, Cobbe SM, Bollen EL, Buckley BM, Ford I, Hyland M, Gaw A, Macfarlane PW, Packard CJ, Norrie J, Perry IJ, Stott DJ, Sweeney BJ, Twomey C, Westendorp RG, Jukema JW (2007) Genetic variation in the interleukin-10 gene promoter and risk of coronary and cerebrovascular events: the PROSPER study. Ann N Y Acad Sci 1100:189–198PubMedCrossRefGoogle Scholar
  298. Tuomisto TT, Binder BR, Ylä-Herttuala S (2005) Genetics, genomics and proteomics in atherosclerosis research. Ann Med 37:323–332PubMedCrossRefGoogle Scholar
  299. Uchida K (2008) A lipid-derived endogenous inducer of COX-2: a bridge between inflammation and oxidative stress. Mol Cells 25:347–351PubMedGoogle Scholar
  300. Um JY, An NH, Kim HM (2003) TNF-alpha and TNF-beta gene polymorphisms in cerebral infarction. J Mol Neurosci 21:167–171PubMedCrossRefGoogle Scholar
  301. van Geel PP, Pinto YM, Zwinderman AH, Henning RH, van Boven AJ, Jukema JW, Bruschke AV, Kastelein JJ, van Gilst WH (2001) Increased risk for ischaemic events is related to combined RAS polymorphism. Heart 85:458–462PubMedCrossRefGoogle Scholar
  302. van Minkelen R, Wettinger SB, de Visser MC, Vos HL, Reitsma PH, Rosendaal FR, Bertina RM, Doggen CJ (2009) Haplotypes of the interleukin-1 receptor antagonist gene, interleukin-1 receptor antagonist mRNA levels and the risk of myocardial infarction. Atherosclerosis 203:201–205PubMedCrossRefGoogle Scholar
  303. Vendrell J, Fernandez-Real JM, Gutierrez C, Zamora A, Simon I, Bardaji A, Ricart W, Richart C (2003) A polymorphism in the promoter of the tumor necrosis factor-alpha gene (−308) is associated with coronary heart disease in type 2 diabetic patients. Atherosclerosis 167:257–264PubMedCrossRefGoogle Scholar
  304. Verma S, Anderson TJ (2002) Fundamentals of endothelial function for the clinical cardiologist. Circulation 105:546–549PubMedCrossRefGoogle Scholar
  305. Voetsch B, Loscalzo J (2004) Genetics of thrombophilia: impact on atherogenesis. Curr Opin Lipidol 15:129–143PubMedCrossRefGoogle Scholar
  306. Voetsch B, Benke KS, Panhuysen CI, Damasceno BP, Loscalzo J (2004) The combined effect of paraoxonase promoter and coding region polymorphisms on the risk of arterial ischemic stroke among young adults. Arch Neurol 61:351–356PubMedCrossRefGoogle Scholar
  307. Vohnout B, Di Castelnuovo A, Trotta R, D’Orazi A, Panniteri G, Montali A, Donati MB, Arca M, Iacoviello L (2003) Interleukin-1 gene cluster polymorphisms and risk of coronary artery disease. Haematologica 88:54–60PubMedGoogle Scholar
  308. Volcik KA, Ballantyne CM, Coresh J, Folsom AR, Boerwinkle E (2007) Specific P-selectin and P-selectin glycoprotein ligand-1 genotypes/haplotypes are associated with risk of incident CHD and ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study. Atherosclerosis 195:e76–e82PubMedCrossRefGoogle Scholar
  309. Wang JG, Staessen JA (2000) Genetic polymorphisms in the renin-angiotensin system: relevance for susceptibility to cardiovascular disease. Eur J Pharmacol 410:289–302PubMedCrossRefGoogle Scholar
  310. Wang XL, Liu SX, McCredie RM, Wilcken DE (1996) Polymorphisms at the 5′-end of the apolipoprotein AI gene and severity of coronary artery disease. J Clin Invest 98:372–377PubMedCrossRefGoogle Scholar
  311. Wang XL, Oosterhof J, Duarte N (1999) Peroxisome proliferator-activated receptor gamma C161→T polymorphism and coronary artery disease. Cardiovasc Res 44:588–594PubMedCrossRefGoogle Scholar
  312. Wang L, Fan C, Topol SE, Topol EJ, Wang Q (2003) Mutation of MEF2A in an inherited disorder with features of coronary artery disease. Science 302:1578–1581PubMedCrossRefGoogle Scholar
  313. Wang X, Ishimori N, Korstanje R, Rollins J, Paigen B (2005a) Identifying novel genes for atherosclerosis through mouse-human comparative genetics. Am J Hum Genet 77:1–15PubMedCrossRefGoogle Scholar
  314. Wang X, Ria M, Kelmenson PM, Eriksson P, Higgins DC, Samnegård A, Petros C, Rollins J, Bennet AM, Wiman B, de Faire U, Wennberg C, Olsson PG, Ishii N, Sugamura K, Hamsten A, Forsman-Semb K, Lagercrantz J, Paigen B (2005b) Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility. Nat Genet 37:365–372PubMedCrossRefGoogle Scholar
  315. Wang L, Hauser ER, Shah SH, Pericak-Vance MA, Haynes C, Crosslin D, Harris M, Nelson S, Hale AB, Granger CB, Haines JL, Jones CJ, Crossman D, Seo D, Gregory SG, Kraus WE, Goldschmidt-Clermont PJ, Vance JM (2007a) Peakwide mapping on chromosome 3q13 identifies the kalirin gene as a novel candidate gene for coronary artery disease. Am J Hum Genet 80:650–663PubMedCrossRefGoogle Scholar
  316. Wang Y, Zheng Y, Zhang W, Yu H, Lou K, Zhang Y, Qin Q, Zhao B, Yang Y, Hui R (2007b) Polymorphisms of KDR gene are associated with coronary heart disease. J Am Coll Cardiol 50:760–767PubMedCrossRefGoogle Scholar
  317. Weng L, Kavaslar N, Ustaszewska A, Doelle H, Schackwitz W, Hébert S, Cohen JC, McPherson R, Pennacchio LA (2005) Lack of MEF2A mutations in coronary artery disease. J Clin Invest 115:1016–1020PubMedGoogle Scholar
  318. Wenzel K, Ernst M, Rohde K, Baumann G, Speer A (1996) DNA polymorphisms in adhesion molecule genes—a new risk factor for early atherosclerosis. Hum Genet 97:15–20PubMedCrossRefGoogle Scholar
  319. Whitfield AJ, Barrett PH, van Bockxmeer FM, Burnett JR (2004) Lipid disorders and mutations in the APOB gene. Clin Chem 50:1725–1732PubMedCrossRefGoogle Scholar
  320. Willer CJ, Sanna S, Jackson AU, Scuteri A, Bonnycastle LL, Clarke R, Heath SC, Timpson NJ, Najjar SS, Stringham HM, Strait J, Duren WL, Maschio A, Busonero F, Mulas A, Albai G, Swift AJ, Morken MA, Narisu N, Bennett D, Parish S, Shen H, Galan P, Meneton P, Hercberg S, Zelenika D, Chen WM, Li Y, Scott LJ, Scheet PA, Sundvall J, Watanabe RM, Nagaraja R, Ebrahim S, Lawlor DA, Ben-Shlomo Y, Davey-Smith G, Shuldiner AR, Collins R, Bergman RN, Uda M, Tuomilehto J, Cao A, Collins FS, Lakatta E, Lathrop GM, Boehnke M, Schlessinger D, Mohlke KL, Abecasis GR (2008) Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet 40:161–169PubMedCrossRefGoogle Scholar
  321. Wilson PW, Schaefer EJ, Larson MG, Ordovas JM (1996) Apolipoprotein E alleles and risk of coronary disease. A meta-analysis. Arterioscler Thromb Vasc Biol 16:1250–1255PubMedGoogle Scholar
  322. Winter JP, Gong Y, Grant PJ, Wild CP (2003) Glutathione peroxidase 1 genotype is associated with an increased risk of coronary artery disease. Coron Artery Dis 14:149–153PubMedCrossRefGoogle Scholar
  323. Wong CW, Christen T, Roth I, Chadjichristos CE, Derouette JP, Foglia BF, Chanson M, Goodenough DA, Kwak BR (2006) Connexin37 protects against atherosclerosis by regulating monocyte adhesion. Nat Med 12:950–954PubMedCrossRefGoogle Scholar
  324. Wong CW, Christen T, Pfenniger A, James RW, Kwak BR (2007) Do allelic variants of the connexin37 1019 gene polymorphism differentially predict for coronary artery disease and myocardial infarction? Atherosclerosis 191:355–361PubMedCrossRefGoogle Scholar
  325. Woo D, Kaushal R, Kissela B, Sekar P, Wolujewicz M, Pal P, Alwell K, Haverbusch M, Ewing I, Miller R, Kleindorfer D, Flaherty M, Chakraborty R, Deka R, Broderick J (2006) Association of Phosphodiesterase 4D with ischemic stroke: a population-based case-control study. Stroke 37:371–376PubMedCrossRefGoogle Scholar
  326. Worrall BB, Azhar S, Nyquist PA, Ackerman RH, Hamm TL, DeGraba TJ (2003) Interleukin-1 receptor antagonist gene polymorphisms in carotid atherosclerosis. Stroke 34:790–793PubMedCrossRefGoogle Scholar
  327. Yamada Y, Izawa H, Ichihara S, Takatsu F, Ishihara H, Hirayama H, Sone T, Tanaka M, Yokota M (2002) Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 347:1916–1923PubMedCrossRefGoogle Scholar
  328. Yamada A, Ichihara S, Murase Y, Kato T, Izawa H, Nagata K, Murohara T, Yamada Y, Yokota M (2004) Lack of association of polymorphisms of the lymphotoxin alpha gene with myocardial infarction in Japanese. J Mol Med 82:477–483PubMedGoogle Scholar
  329. Yang Q, Khoury MJ, Botto L, Friedman JM, Flanders WD (2003) Improving the prediction of complex diseases by testing for multiple disease-susceptibility genes. Am J Hum Genet 72:636–649PubMedCrossRefGoogle Scholar
  330. Ye S, Watts GF, Mandalia S, Humphries SE, Henney AM (1995) Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis. Br Heart J 73:209–215PubMedCrossRefGoogle Scholar
  331. Ye S, Eriksson P, Hamsten A, Kurkinen M, Humpries SE, Henney AM (1996) Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression. J Biol Chem 271:13055–13060PubMedCrossRefGoogle Scholar
  332. Ye S, Gale CR, Martyn CN (2003) Variation in the matrix metalloproteinase-1 gene and risk of coronary heart disease. Eur Heart J 24:1668–1671PubMedCrossRefGoogle Scholar
  333. Ye Z, Liu EH, Higgins JP, Keavney BD, Lowe GD, Collins R, Danesh J (2006) Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66,155 cases and 91,307 controls. Lancet 367:651–658PubMedCrossRefGoogle Scholar
  334. Yeh HI, Chou Y, Liu HF, Chang SC, Tsai CH (2001) Connexin37 gene polymorphism and coronary artery disease in Taiwan. Int J Cardiol 81:251–255PubMedCrossRefGoogle Scholar
  335. Yokota M, Ichihara S, Lin TL, Nakashima N, Yamada Y (2000) Association of a T29-NC polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to myocardial infarction in Japanese. Circulation 101:2783–2787PubMedGoogle Scholar
  336. Zacho J, Tybjaerg-Hansen A, Jensen JS, Grande P, Sillesen H, Nordestgaard BG (2008) Genetically elevated C-reactive protein and ischemic vascular disease. N Engl J Med 359:1897–1908PubMedCrossRefGoogle Scholar
  337. Zambon A, Deeb SS, Pauletto P, Crepaldi G, Brunzell JD (2003) Hepatic lipase: a marker for cardiovascular disease risk and response to therapy. Curr Opin Lipidol 14:179–189PubMedCrossRefGoogle Scholar
  338. Zee RY, Cheng S, Hegener HH, Erlich HA, Ridker PM (2006) Genetic variants of arachidonate 5-lipoxygenase-activating protein, and risk of incident myocardial infarction and ischemic stroke: a nested case-control approach. Stroke 37:2007–2011PubMedCrossRefGoogle Scholar
  339. Zee RY, Hennessey H, Michaud SE, Ridker PM (2008) Genetic variants within the interleukin-1 gene cluster, and risk of incident myocardial infarction, and ischemic stroke: A nested case-control approach. AtherosclerosisGoogle Scholar
  340. Zhang B, Ye S, Herrmann SM, Eriksson P, de Maat M, Evans A, Arveiler D, Luc G, Cambien F, Hamsten A, Watkins H, Henney AM (1999) Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation 99:1788–1794PubMedGoogle Scholar
  341. Zhang K, Zhang S, Zheng K, Hou Y, Liao L, He Y, Zhang L, Nebert DW, Shi J, Su Z, Xiao C (2004) Novel P143L polymorphism of the LCAT gene is associated with dyslipidemia in Chinese patients who have coronary atherosclerotic heart disease. Biochem Biophys Res Commun 318:4–10PubMedCrossRefGoogle Scholar
  342. Zhang Y, Da Silva JR, Reilly M, Billheimer JT, Rothblat GH, Rader DJ (2005) Hepatic expression of scavenger receptor class B type I (SR-BI) is a positive regulator of macrophage reverse cholesterol transport in vivo. J Clin Invest 115:2870–2874PubMedCrossRefGoogle Scholar
  343. Zhao J, Zhou X, Huang J, Chen J, Gu D (2005) Association study of the thrombomodulin −33G>A polymorphism with coronary artery disease and myocardial infarction in Chinese Han population. Int J Cardiol 100:383–388PubMedCrossRefGoogle Scholar
  344. Zhou X, Huang J, Chen J, Zhao J, Ge D, Yang W, Gu D (2004a) Genetic association analysis of myocardial infarction with thrombospondin-1 N700S variant in a Chinese population. Thromb Res 113:181–186PubMedCrossRefGoogle Scholar
  345. Zhou X, Huang J, Chen J, Zhao J, Yang W, Wang X, Gu D (2004b) Thrombospondin-4 A387P polymorphism is not associated with coronary artery disease and myocardial infarction in the Chinese Han population. Clin Sci (Lond) 106:495–500CrossRefGoogle Scholar
  346. Zwicker JI, Peyvandi F, Palla R, Lombardi R, Canciani MT, Cairo A, Ardissino D, Bernardinelli L, Bauer KA, Lawler J, Mannucci P (2006) The thrombospondin-1 N700S polymorphism is associated with early myocardial infarction without altering von Willebrand factor multimer size. Blood 108:1280–1283PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  • Himadri Roy
    • 1
  • Shalini Bhardwaj
    • 1
  • Seppo Yla-Herttuala
    • 1
  1. 1.Department of Molecular Medicine and Biotechnology, A.I. Virtanen InstituteUniversity of KuopioKuopioFinland

Personalised recommendations